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Abstract 
 
Stem cells are undifferentiated cells with the ability to self-renew and differentiate into specialized cells, 
under appropriate conditions. During gastrulation cells rearrange themselves transforming the early 
embryo into a multi-layered structure containing three germ layers, endoderm, mesoderm and ectoderm. 
Accordingly, pluripotent stem cells (PSC), e.g. embryonic stem cells (ESC) or induced pluripotent stem 
cells (iPSC), differentiate into cells of all three primitive germ layers. Differentiating stem cells negotiate 
branching lineage choices, avoiding alternate fates to decisively commit to a single lineage. However, 
the regulatory mechanisms underlying PSC differentiation into specific lineages remain elusive. 
Here, we define a representative roadmap for early human development and reconstruct the 
differentiation trajectories by which pluripotent cells sequentially elaborate diverse neuroectodermal, 
cardiac mesodermal and hepatic endodermal progeny. Tracking these three-germ layer-derived lineage-
choices in vitro uncovers the sequential molecular events that ultimately lead to the establishment of 
different cell types. Therefore, we provide a comprehensive study through transcriptomic and network 
modeling approaches, based on RNA-Sequencing data, to investigate the critical changes that may occur 
during human early cardiogenesis, neurogenesis and hepatogenesis, mimicked by human PSC-derived 
cardiomyocytes, neurons and hepatocytes. In addition, published datasets were also analysed to cover 
multiple cellular lineages and construct the developmental trajectories of cells derived from all three 
germ layers, as well as to identify key lineage specifiers. This paved the way for a deeper understanding 
of the regulatory mechanisms driving distinct cellular subpopulations present at each differentiation 
stage. To that aim, we have developed two main approaches, one comprising global gene expression of 
lineage specifiers and another focusing solely on genes encoding transcription factors, as key regulators 
of cellular decisions. Interestingly, this transcriptomic analysis allowed us to identify novel key putative 
regulators of cardiogenesis (HOXB4, HOXB5, HOXB6 and RARB) and neurogenesis (TERF2IP, RFX4 
and ZHX1), whose expression results throughout differentiation have been validated by Quantitative 
Real Time Polymerase Chain Reaction. 
Collectively, these data provide a starting point to better understand the mechanisms that control 
human PSC fate transitions, revealing the cellular landscape of human PSC early differentiation. We 
expect that this knowledge might one day be exploited for developmental cell biology, regenerative 
medicine, disease modeling and drug discovery applications. 
 
KEYWORDS  
Stem Cell Fate, Transcriptomic Analysis, Human Induced Pluripotent Stem Cells, Cardiac 
Differentiation, Neuronal Differentiation 
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Resumo  
 
 
As células estaminais são células indiferenciadas com a capacidade de auto-renovação e diferenciação 
em células especializadas, em condições apropriadas. Desempenham funções fundamentais em diversas 
fases do desenvolvimento, podendo ser totipotentes, pluripotentes, multipotentes e unipotentes.  
As células estaminais pluripotentes humanas (hPSC), incluindo células estaminais embrionárias 
humanas (hESC) e células estaminais pluripotentes induzidas humanas (hiPSC), têm como principais 
aplicações a descoberta de fármacos, a modelação de doenças e a medicina regenerativa. 
O desenvolvimento embrionário humano inicia-se com a fusão dos gâmetas masculino e feminino, 
gerando-se reprogramações epigenéticas, uma série de divisões mitóticas (clivagem), degradação dos 
transcriptos maternos e ativação do genoma embrionário. De seguida, o embrião sofre compactação e 
cavitação, passando pelo estágio de mórula, até formar a blástula. A massa celular interna (ICM) do 
blastocisto diverge entre as células do epiblasto e da endoderme primitiva (hipoblasto), seguindo-se a 
implantação do blastocisto e gastrulação. 
Durante a gastrulação as células rearranjam-se, transformando o embrião numa estrutura contendo 
três camadas germinativas - ectoderme, mesoderme e endoderme. De forma semelhante, muitos métodos 
de diferenciação in vitro visam o comprometimento de hPSC numa linhagem multipotente, que dará 
origem ao tipo celular de interesse. Deste modo, a diferenciação de hPSC numa linhagem celular 
pretendida requer a regulação complexa de diversas vias de sinalização, através de fatores de 
crescimento, citocinas e pequenas moléculas. 
Quando as hPSC são induzidas com Wnt, Activina A ou BMP4, estas células formam uma 
população semelhante à linha primitiva e subsequentemente, a mesoderme ou endoderme. As células da 
linha primitiva posterior dão origem à mesoderme, seguindo-se a formação da mesoderme cardíaca e 
dos progenitores cardíacos, os quais geram células diferenciadas. Alternativamente, as células da linha 
primitiva anterior podem ser induzidas por Activina/Nodal e deste modo formar endoderme definitiva 
FOXA2+, seguindo-se a formação de hepatoblastos, que irão dar origem a hepatócitos. Caso estas vias 
não sejam ativas, as hPSC irão diferenciar-se em ectoderme. A diferenciação de hiPSC em neurónios 
transita através de diversos estadios intermediários. As hiPSC diferenciam-se em progenitores 
neurais/células estaminais neuroepiteliais que se assemelham às células estaminais neurais (NSC), que 
formam o tubo neural in vivo. Durante a neurulação in vivo, o tubo neural fecha e formam-se os primeiros 
tipos de neurónios. O passo correspondente in vitro é a formação de rosetas neurais, que irão dar origem 
a células da glia e neurónios. 
A investigação dos mecanismos que regulam as decisões celulares e especificação de sub-
populações é fundamental para uma melhor compreensão do desenvolvimento humano embrionário in 
vivo e sua modelação in vitro. Este conhecimento poderá vir a ser explorado para a medicina 
regenerativa, modelação de doenças e descoberta de fármacos. No entanto, abordagens sistemáticas para 
a cultura e diferenciação de células estaminais permanecem pouco desenvolvidas. Esta necessidade 
tecnológica surgiu como o grande propósito deste estudo, sendo o seu objetivo principal a análise de 
processos robustos e reprodutíveis para a diferenciação de hPSC. 
Com este fim, começámos por expandir uma base de dados génica, de modo a abranger o maior 
número possível de genes associados à especificação de linhagens celulares derivadas de cada uma das 
três camadas germinativas. De seguida, analisámos as proteínas codificadas pelos genes dessa base de 
dados aumentada, de modo a identificar quais os processos biológicos e vias de sinalização enriquecidos 
associados. 
Ainda, foi possível delinear um percurso representativo do desenvolvimento humano, 
reconstruindo-se as trajetórias de diferenciação pelas quais as hPSC elaboram sequencialmente uma 
diversidade de linhas celulares derivadas da neuroectoderme, mesoderme cardíaca e endoderme 
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hepática. Esta abordagem revelou os eventos moleculares sequenciais que regulam o estabelecimento 
dos três diferentes tipos celulares analisados. 
Para este estudo desenvolveram-se abordagens de transcriptómica e de modelação de redes, com 
base nos dados de sequenciação de RNA (RNA-Seq) de células diferenciadas. Esta análise permitiu 
revelar as vias de sinalização e perfis de expressão génica responsáveis pela indução eficiente de cada 
uma destas linhagens em diversos pontos temporais. Esta estratégia foi desenvolvida ao nível da 
expressão global de genes e, posteriormente, com enfoque exclusivo em genes que codificam fatores de 
transcrição, uma vez que estes controlam uma rede regulatória de programas de expressão génica, 
despoletando diversas respostas celulares. Deste modo, desenvolveu-se uma análise que incluiu a 
normalização de dados, visualização de dados de transcriptómica por heatmaps, PCAs (Principal 
Component Analysis) e diagramas de Venn, e investigação dos processos biológicos e principais vias de 
sinalização associados à expressão génica.  
Demonstrou-se que os cardiomiócitos derivados de hiPSC (hiPSC-CM) e os neurónios derivados de 
hiPSC (hiPSC-Neurons) exibiram uma diferenciação progressiva robusta, quando comparados a tecidos 
fetais e adultos cardíacos e cerebrais, respetivamente. Deste modo, em termos de expressão génica, os 
nossos métodos de diferenciação cardíaca e neural revelaram-se bem sucedidos. 
Realizou-se ainda uma comparação entre os protocolos que estabelecemos para a diferenciação 
cardíaca e neural com protocolos distintos para a obtenção dos mesmos tipos celulares, embora por 
intermédio de diferentes linhas celulares, fatores de diferenciação e/ou meios de cultura. Apesar destas 
diferenças, uma análise de PCA mostrou que os diversos grupos surgiram por ordem cronológica, 
claramente distinguindo as amostras de diferentes estadios de diferenciação, permitindo definir as 
trajetórias de linhagens celulares, validando a nossa eficiência de diferenciação. 
Adicionalmente, foi analisada a expressão de genes que apenas codificam fatores de transcrição, 
regulando a diferenciação de hiPSC-CM, hiPSC-Neurons e de hepatócitos derivados de hESC. A análise 
de PCA evidenciou a existência de diferenças consideráveis entre estas três diferenciações, dada a 
existência de redes génicas distintas a regular linhagens celulares específicas. 
De seguida, procurou-se identificar os padrões de expressão génica que modulam a especificação 
progressiva da ectoderme e da mesoderme, bem como os seus principais papéis funcionais. Assim, 
compararam-se as alterações de expressão génica em fases sequenciais da diferenciação neural e 
cardíaca, juntamente como uma análise dos genes diferencialmente expressos (DEGs) (Differentially 
Expressed Genes) no Gene Ontology (GO). Esta abordagem foi desenvolvida tanto a um nível global de 
expressão de genes, como posteriormente direcionada apenas para genes que codificam fatores de 
transcrição. Ambas demonstraram diferenças consideráveis entre os DEGs durante a diferenciação em 
ectoderme comparativamente à diferenciação em mesoderme, em termos de expressão de genes e suas 
funções associadas, bem como na modulação de vias de sinalização, os quais foram devidamente 
identificados. Estes resultados permitiram comparar e discriminar as principais alterações de expressão 
génica e respetivos processos biológicos enriquecidos, durante a transição de um estado de pluripotência 
para um comprometimento em ectoderme ou mesoderme. 
Adicionalmente, foi feito um screening de genes que apenas codificam fatores de transcrição em 
fases comuns da diferenciação em três datasets (hiPSC-Neurons, hiPSC-CM e hepatócitos derivados de 
hESC). Deste modo, foi possível identificar que fatores de transcrição estão particularmente envolvidos 
em fases sequenciais da especificação de cada camada germinativa. 
Para concluir, realizou-se um estudo do perfil de alterações transcripcionais em fases sequenciais, 
através da comparação de dois datasets de RNA-Seq para cada tipo de diferenciação. Esta estratégia foi 
utilizada para analisar com maior precisão alterações determinadas e suportadas por ambos os datasets 
para cada tipo de diferenciação, validando as nossas observações. Apesar das diferenças entres os 
protocolos de diferenciação e linhas celulares utilizadas, os dois tipos de neurónios diferenciados 
continuaram a exibir transcriptomas altamente concordantes durante a diferenciação neural, 
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evidenciados por picos específicos de expressão génica que ocorreram aproximadamente nos mesmos 
pontos temporais da diferenciação, apresentando tendências similares de expressão. O mesmo se 
observou entre os dois datasets cardíacos que foram analisados. 
Esta investigação permitiu ainda identificar novos reguladores putativos da cardiogénese (HOXB4, 
HOXB5, HOXB6 e RARB) e neurogénese (TERF2IP, RFX4 e ZHX1), os quais foram subsequentemente 
validados por Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR). Globalmente, os 
resultados obtidos por qRT-PCR foram concordantes com os dados de RNA-Seq. Adicionalmente, a 
eficiência da diferenciação cardíaca foi confirmada por citometria de fluxo, validando assim os 
resultados obtidos por qRT-PCR ao longo da diferenciação. 
A caracterização transcriptómica efetuada definiu um mapeamento representativo do 
desenvolvimento da neuroectoderme e mesoderme cardíaca, revelando picos de expressão temporal quer 
de marcadores específicos de cada linhagem, quer de novos candidatos envolvidos na diferenciação. 
Estes resultados evidenciaram uma diferenciação eficiente de hPSC nos tipos celulares pretendidos. 
Em suma, este estudo pretendeu contribuir para a análise de modelos de cultura celular que possam 
mimetizar a função in vivo, apresentando dados que poderão ser utilizados futuramente na otimização 
de protocolos de diferenciação. Deste modo, pretendemos fornecer informação importante relativa aos 
mecanismos que controlam as transições das hPSC, com implicações no conhecimento acerca da 
diferenciação de células estaminais em diferentes linhagens celulares, na biologia celular e do 
desenvolvimento, e na medicina regenerativa. Esperamos que esta área de investigação se mantenha 
altamente dinâmica num futuro próximo. 
 
PALAVRAS-CHAVE 
Análise Transcriptómica, Células Estaminais Pluripotentes Induzidas Humanas, Diferenciação 
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1 Introduction  
1.1 Stem Cells 
Stem cells are undifferentiated cells with the ability to self-renew (generate undifferentiated daughter 
cells to preserve stem cell populations) and to differentiate into specialized cells, under appropriate 
conditions. They play essential roles at diverse stages of development and present distinct potential fates 
- Totipotent, Pluripotent, Multipotent, and Unipotent.1-3.  
Therefore, the zygote and early blastomeres form all the embryonic tissues and the extraembryonic 
ones (yolk sac, amnion and placenta), a capacity termed totipotency. However, the zygote is hardly 
considered a stem cell in mammals, since it cleaves into blastomeres of equal developmental potency 
for at most three cell divisions, and subsequently displays very limited self-renewal potential2. 
Pluripotent stem cells (PSC), e.g. embryonic stem cells (ESC) or induced pluripotent stem cells 
(iPSC) differentiate into cells of all three primitive embryonic germ layers – ectoderm, mesoderm and 
endoderm1, although they exhibit limited contribution to extraembryonic tissues4. These cells are 
isolated from the inner cell mass (ICM) of blastocysts and cultured as immortal cell lines (ESC),5 or 
they can be induced from somatic cells by direct reprogramming with defined transcription factors 
(iPSC)6. PSC are also able to contribute to chimera formation/blastocyst complementation and to form 
teratomas, while iPSC reactivate telomerase gene expression7,1. The terms ‘naive’ and ‘primed’ describe 
the early and late phases of epiblast (EPI) ontogeny, pre and post-implantation, respectively, and its 
respective derivatives. Thereby, human pluripotent stem cells (hPSC) are classified as ‘primed’, being 
enriched in repressive chromatin features 5,8. 
Multipotent stem cells differentiate into multiple cell types restricted to one lineage, e.g. 
hematopoietic stem cells (HSC), which form blood cells and immune cells; mesenchymal stromal cells 
(MSC), which form osteoblasts, chondrocytes and fat cells; neuronal stem cells (NSC), which form 
neurons, astrocytes and oligodendrocytes; and intestinal stem cells1,2,9.  
Unipotent stem cells, such as satellite, epidermal and spermatogonial stem cells, differentiate into 
only one cell type, e.g. to skeletal muscle, keratinocytes, or sperm, respectively8. Moreover, adult stem 
cells are either multipotent or unipotent and mainly reside in specialized niches1.  
 
1.1.2 Applications of Stem Cells 
Recently, there has been an increasing interest in developing cell therapies to potentially replace 
diseased or damaged tissues10. To this aim, the choice of stem cell type and application is conditioned 
by the accessibility of the cell type, its potential benefits and risks, and the likelihood of its translation 
to clinical trials11. 
hPSC, including human ESC (hESC) and human induced pluripotent stem cells (hiPSC), have three 
main applications – disease modeling, drug screening and regenerative medicine12.  
hiPSC derived from patients and healthy individuals combined with efficient gene modification 
technologies have led to novel opportunities to model human diseases, in order to understand their 
mechanisms, and finding ways to delay or reverse them in vivo. However, many diseases have 
multicellular contributions. Therefore, the next generation of disease models is increasingly based on 
combinations of cell types, sometimes in ‘‘organ-on-chip’’ formats, microfluidic devices that integrate 
several cell types of various developmental lineages in chips13. Alternatively, we could use 
‘‘organoids,’’ three-dimensional (3D) in vitro culture systems that recapitulate the in vivo architecture, 
physiology and genetic information of original tissues, resembling an organ14. Models based on hiPSC 
have many advantages in comparison with hESC, since they can provide rapid readouts of disease 
pathology and be employed as drug screening platforms for the development and validation of 
therapeutic compounds, either as target-based screening or phenotypic screening12,15. Moreover, hiPSCs 
represent attractive cell sources since they are isolated from accessible cell types, easily expanded ex 
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vivo, and able to differentiate into nearly any cell type, providing high quantities of cells. The major 
limitations that still need further optimization include the lack of mature structural and functional 
phenotypes in hPSC derivatives, low reproducibility, and the degree of complexity that can be achieved 
with in vitro stem cell models12,13.  
In addition, hPSC can potentially be used for regenerative medicine, to promote endogenous 
regenerative processes or replace damaged tissues after cellular transplantation12. To this aim, “3D 
patch-based platforms” have been extensively studied for regeneration. They are composed of 
biomaterials either with or without cells and once transplanted, they provide biological therapeutics and 
growth factors16. The major concerns before these type of approaches reach clinical trials comprise the 
reprogramming efficiency to generate hiPSC, which currently has low yield, and the risk of malignant 
transformation due to the presence of the oncogene C-MYC used in the reprogramming procedure17. 
Although differentiated cells derived from iPSC do not generate teratomas, it is critical to ensure that 
the final product does not contain undifferentiated cells that present the risk of tumorigenesis. Moreover, 
there is also a risk of acquiring somatic mutations and chromosomal rearrangements during the induction 
of pluripotency, and there have been reports of genetic and epigenetic variation between iPSC lines that 
were derived using the same methods12. Therefore, improved protocols to differentiate hPSC into 
desired cell types with precise identity and cellular functions are required, which could be achieved with 
techniques to sort the iPSC-derived cells before transplantation, using magnetic or fluorescence-
activated cell sorting (MACS or FACS). Also, the risk of tumorigenicity can be tested in animal models 
prior transplantation12. Another concern arises when cells are allogeneic, potentially leading to 
immunological rejection unless immunosuppression or other strategies are applied10,18, as reported 
elsewhere19. Hence, to circumvent this latter issue, patient-specific hiPSC seems to be a promising 
strategy for cell replacement therapy10,17.  
 
1.2 Early Human Development: Cleavage, Gastrulation, and Axis Formation  
Human development begins with the fusion of the egg and sperm pronuclei, encompassing epigenetic 
reprogramming and modification, a series of cleavage divisions leading to an extensive wave of 
degradation of maternal transcripts, and embryonic genome activation (EGA). EGA occurs between the 
4- and 8-cell stages, consisting of newly synthesized transcripts by the embryo20,21. Cleavage is a series 
of mitotic divisions that immediately follow fertilization, in which the net size of the embryo remains 
the same, resulting in numerous smaller cells called blastomeres. In humans, there are three cleavage 
divisions from 1 cell to 2 cells, 2 cells to 4 cells and 4 cells to 8 cells20,22. Following EGA, the embryo 
subsequently undergoes compaction, when blastomeres adhere to each other to form the morula, and 
then cavitation. Cavitation leads to the formation of a blastocyst, that comprises a fluid-filled cavity and 
an ICM surrounded by trophectoderm (TE) cells. TE consists of extra-embryonic cells that, upon 
implantation, give rise to the placental cytotrophoblast and syncytiotrophoblast. Furthermore, ICM 
diverges into early EPI and primitive endoderm (hypoblast) cells (Fig. 1.1), followed by implantation at 
approximately day 7 of development20.  
The blastocyst comprises three cell lineages: pluripotent EPI cells that form the embryo; and 
extraembryonic TE and primitive endoderm (PE) cells, that contribute to the placenta and yolk sac, 
respectively23 (Fig. 1.1). During compaction in mouse, the first cell fate decision, which segregates the 
ICM and TE, involves differential Hippo signaling (active in the ICM and blocked in TE), due to 
mechanisms of cell-cell contact. Therefore, in the first decision, OCT4 mutually represses CDX2 
expression, enabling some cells to become pluripotent in the ICM and other cells to originate the TE, 
respectively24. In the second cell fate decision, the segregation of the EPI and PE lineages within the 
ICM involves differential fibroblast growth factor (FGF) signaling, where cells receiving higher levels 
of FGF become PE25. Therefore, ICM cells express key transcription factors (TFs), such as NANOG and 
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SOX2 (EPI) and GATA6, GATA4, SOX17 (PE)23,26,27. However, there has been evidence suggesting that 
the formation of human PE does not depend on FGF signaling, conversely to the mouse27. 
Furthermore, during gastrulation cells rearrange themselves transforming the early embryo into a 
multi-layered structure containing three germ layers, endoderm, mesoderm and ectoderm28 (Fig. 1.1). 
At the primitive streak, EPI cells undergo an epithelial to mesenchymal transition (EMT), whereby 
epithelial cells are transformed into migratory mesenchymal cells29, and then move away from the streak 
to become incorporated into either the definitive endoderm or the extraembryonic mesoderm and 
embryonic mesoderm30. Specific fates are related with the proximal-distal axis of the embryo where 
cells move through and away from the streak. These cells appear to be capable of both synthesizing and 
responding to FGFs, particularly signaling via FGF8 and/or FGF4. Conversely, cells that never traverse 
the streak are fated to form neuroectoderm and surface ectoderm31.  
 
Fig. 1.1 Lineage specification and cell fate decisions. 
After the implantation of the blastocyst, the trophoblast develops through various stages, generating the embryonically 
derived portion of the placenta. The inner cell mass (ICM) originates the epiblast (EPI) and the hypoblast (primitive 
endoderm). The EPI gives rise to the embryo and amnion, while the hypoblast generates the yolk sac cells. (Adapted 
from Gilbert and Barresi, 2016).  
 
Additionally, embryos must develop three definitive axes: the anterior-posterior (A-P) axis, the 
dorsal-ventral (D-V) axis, and the right-left axis. The mammalian embryo has two signaling centers: 
one in the node (responsible for neural induction and for the patterning of most of the A-P axis), and 
one in the anterior visceral endoderm (AVE) (crucial for positioning the primitive streak)32. The 
primitive streak and other posterior tissues are the sources of wingless integrated (Wnt), bone 
morphogenetic proteins (BMP) and FGF proteins. Conversely, the AVE produces antagonists of these 
paracrine factors on the anterior side of the embryo33. 
 
1.3 Ectoderm Development 
1.3.1 The Vertebrate Nervous System and Epidermis 
Ectoderm, the outer germ layer covering late-stage gastrula, has three major roles: one part of the 
ectoderm will become the neural plate, which will involute and form the neural tube, the precursor of 
the central nervous system (CNS). The neural tube gives rise to the brain at the anterior, and spinal cord 
at the posterior end34. At the neural plate and neural tube stages, secondary organizers regulate the 
antero-posterior specification of distinct neural regions35. Another part of the ectoderm will give rise to 
the epidermis, the outer layer of the skin, on the ventral side. Between the compartments forming the 
epidermis and the CNS lies the presumptive neural crest, where the ventral and dorsal boundaries meet. 
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This progenitor cell population delaminates and migrates away to form, among other things, the 
peripheral nervous system (all the nerves and neurons lying outside the CNS), cartilage and bone of the 
face and pigment cells (melanocytes)34,36. The processes by which the three ectodermal regions are 
formed is called neurulation, and an embryo undergoing these processes is called a neurula.  
The cells of the neural plate are characterized by expression of the Sox family of TFs (SOX1, 2, and 
3), which activate the genes that specify cells to become neural plate and inhibit the formation of 
epidermis and neural crest by blocking the transcription and signaling of BMPs37. Evidence has shown 
that neural induction involves suppression of an epidermal fate rather than induction of a neural fate, 
therefore the default state of the naive ectoderm is neural, not epidermal38. 
 
1.3.2 Neural Tube Formation and Patterning 
The neural tube is polarized along a D-V axis. The Sonic hedgehog (Shh) protein derives from the 
notochord and ventral floor plate and promotes ventral identity by repressing dorsal fate, whereas 
members of both Wnt and BMP families are secreted from the roof plate and surface ectoderm, 
favouring dorsal identities. Additional activities have also been reported to non‐BMP members of the 
transforming growth factor beta (TGFβ) superfamily, as well as retinoic acid (RA)39. The dorsal region 
is associated with sensory circuits, due to BMP activity, whereas the ventral region comprises the motor 
neurons, favoured by Shh activity. In the middle, there are numerous interneurons40. 
Cells in the posterior regions of the neural tube begin as neuromesodermal progenitors (NMPs), that 
can give rise to either neural or somitic cell types from the paraxial mesoderm. NMPs are born in the 
caudal lateral EPI and are positively maintained by FGF and Wnt signals during tailbud elongation. 
Conversely, RA is expressed by somitic mesoderm and inhibits FGF signaling. Therefore, if an NMP 
cell enters the neural mesenchyme, it becomes a preneural progenitor cell with the ability to respond to 
either Shh or BMP signals. Then, preneural progenitors become proneural progenitors when exposed to 
lower gradients of FGF/Wnt and moderate levels of RA41. 
NSC generate new neurons or glial cells in the wall of the neural tube, in the ventricular zone. 
Newborn neurons can migrate away from the ventricular zone and form a new layer, the mantle or 
intermediate zone (gray matter), and can migrate towards the marginal zone. This process forms the 
cortical layers of the brain42. The adult brain has two NSC pools located in the sub-ventricular zone and 
the sub-granular zone of the dentate gyrus of the hippocampus. The majority of NSC are quiescent (type 
B1q cells) and generate proliferative, activated NSC (type B1a cells), which can, in turn, produce neural 
progenitor cells (NPC or transient amplifying progenitor [TAPs] or type C cells), a proliferative cell 
population that expresses markers of early neuronal differentiation. Finally, the NPC give rise to 
neuroblasts (type A cells), which migrate to the olfactory bulb where they become primarily 
interneurons43. The brain forms three primary vesicles, the prosencephalon (forebrain), mesencephalon 
(midbrain), and rhombencephalon (hindbrain). The prosencephalon and rhombencephalon become 
further subdivided44. 
 
1.4 Mesoderm Development  
1.4.1 Mesodermal Subtypes 
The formation of mesodermal tissues in the embryo occurs synchronously with the neural tube 
development. The notochord extends beneath the neural tube, from the posterior region of the 
forebrain into the tail. On either side of the neural tube lie mesodermal cells, that become further 
divided into mesodermal subtypes. Mesoderm development begins with the formation of the primitive 
streak, which then segregates into mesodermal subtypes - chordamesoderm, paraxial, intermediate, 
and lateral plate mesoderm45-47.  
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Chordamesoderm, or axial mesoderm, is the central region of trunk mesoderm and generates the 
notochord, a transient tissue responsible for the induction and patterning of the neural tube and body 
axis formation48. 
Paraxial mesoderm is derived from the anterior primitive streak and segments into somites, which 
are epithelial building blocks on either side of the neural tube46. The anterior-most paraxial mesoderm 
does not segment, forming the head mesoderm, providing the mesenchyme and musculature of the 
head49. In the segmented paraxial mesoderm, somites are patterned along the D-V axis, where the ventral 
somite (sclerotome) gives rise to bone and cartilage, while the dorsal somite (dermomyotome) generates 
brown fat, dermis and skeletal muscle46.  
The intermediate mesoderm is adjacent to the paraxial mesoderm and forms the urogenital system - 
kidneys, gonads, and their associated ducts50. 
Farthest away from the notochord, the lateral mesoderm derives from the middle primitive streak 
and resides on either side of the two bands of intermediate mesoderm. The lateral plate mesoderm 
furtherly splits into the somatic and splanchnic layers, giving rise to limb bud mesoderm51 and cardiac 
mesoderm46, respectively.  
 
1.4.2 Cardiac Development 
The heart is the first organ to function during embryogenesis and is specified through the interaction 
between inductive and inhibitory cues from the adjacent endoderm and ectoderm. The next step in 
cardiogenesis is the specification and differentiation of cardiac cells, orchestrated by distinct multipotent 
progenitor populations, the first heart field (FHF), and the second heart field (SHF)52-54. The FHF forms 
the cardiac crescent and leads to the formation of a linear heart tube, giving rise primarily to the left 
ventricle and a fraction of the atria. Progenitors from the anterior SHF contribute to the right ventricle 
and the outflow tract, whereas the posterior SHF cells generate the atria and the inflow tract. Lineage-
tracing studies indicate that both heart fields are marked by expression of Flk-1 and the TF NKX2-5, 
while the TF ISL1 selectively marks the SHF55-57. In addition, there is also a contribution from the 
proepicardial organ and cardiac neural crest cells to the heart development. The proepicardium is a 
transient structure that eventually starts to give rise to the epicardium, which, in turn, can contribute to 
several lineages within the heart58. The cardiac neural crest cells contribute to the septation of the 
outflow tract, to the parasympathetic innervation, and to the formation of heart valves53. Subsequently, 
the linear heart tube undergoes rightward looping and remodeling events of chamber formation, 
septation, and valve development lead to the formation of the four-chambered heart53,59, where TF 
encoding genes such as TBX5 and TBX20, in combination with NKX2-5 and GATA4, have shown to play 
a regulatory role60.  
The early embryonic heart tube comprises the endocardium, the inner endothelial layer; 
myocardium, muscular middle layer; and the epicardium, outer epithelial layer, derived from the 
proepicardium61. The heart is composed by different cells – cardiac fibroblasts; atrial and ventricular 
myocytes; smooth muscle that generate the venous and arterial musculature; the endothelial lining of 
the heart and valves; and the epicardium61,62.  
 
1.5 Endoderm Development 
1.5.1 Tubes and Organs for Digestion and Respiration 
The endoderm has three major embryonic functions – to induce the formation of several mesodermal 
organs, such as notochord, heart and blood vessels, which, in turn, help specify the endoderm; to form 
the respiratory and gastrointestinal tracts, and all of their associated organs; and to generate the 
epithelium of several glands63,64. 
The endoderm arises from two sources. The main source is the set of cells that migrate through the 
primitive streak during gastrulation and segregate from bipotential mesendoderm (transient common 
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precursor cell population that gives rise to both mesoderm and endoderm), to form definitive endoderm 
(DE). This source of cells replaces part of the extraembryonic visceral endoderm that gives rise to the 
yolk sac63. The DE is a monolayer of cells on the ventral side of the developing embryo, which then 
forms a tube as the embryo rotates along the A-P axis and is patterned into three progenitor domains, 
that comprise the foregut, midgut and hindgut65. Nodal signaling drives the expression of a conserved 
network of TFs within the endodermal lineage, including MIX-like proteins: FOXA2, SOX17, EOMES 
and GATA4-6. These factors activate then a cascade of genes that function to segregate endoderm and 
mesoderm lineages, specify cells to an endodermal fate, and integrate signaling events that pattern the 
nascent endoderm. Therefore, the fate choice between endoderm and mesoderm appears to depend on 
the concentration of Nodal secreted from the visceral endoderm, where high levels of Nodal induce the 
endodermal network of TFs, while BMPs and FGFs act against Nodal and specify migrating cells to 
become mesoderm66. 
The DE of the gut is then defined along the A-P axis. This axis in vertebrates is specified by gradients 
of Wnts, FGFs, and BMPs, each of which has highest concentrations posteriorly. The endoderm near 
the head will form the anterior foregut cells, which will generate the precursors of the lung and thyroid 
glands. The endoderm in the posterior becomes a collection of midgut-hindgut precursor cells and will 
form the intestinal progenitor cells. The region between them, in the area of moderate BMPs, FGFs, and 
Wnts, becomes the posterior foregut precursors, generating the pancreas and the liver65.  
 
1.5.2 Hepatic Development 
The hepatic diverticulum (or liver bud) thickens and transitions from a monolayer of cuboidal endoderm 
cells into a multilayer of pseudostratified cells called hepatoblasts, which delaminate, proliferate and 
migrate to the surrounding septum transversum, forming the liver bud67. Then, the diverticulum extends 
away from the foregut into the surrounding mesenchyme, which stimulates the endoderm to proliferate, 
branch, and form the glandular epithelium of the liver66.  
The mature human liver has four lobes containing different cell types, such as hepatocytes, the main 
parenchymal cells of the liver, constituting ∼80% of its mass and regulating body metabolism; 
cholangiocytes, epithelial cells that line the bile ducts; sinusoidal endothelial cells65, creating the blood 
channels in the liver68; stellate cells, the main mesenchymal component of the liver; and Kupffer cells, 
liver macrophages located in the sinusoids65. Hepatoblasts are marked by the expression of alpha-
fetoprotein and albumin, as well as markers for both hepatocytes (albumin, HNF4α, keratin) and 
cholangiocytes (CK19). Hepatoblasts proliferate and differentiate into hepatocytes and cholangiocytes65. 
 
1.6 Pluripotent Stem Cell Signalling throughout In Vitro Differentiation 
Derivation of hPSC into a specific lineage or cell type requires the regulation of distinct signaling 
pathways (Fig. 1.2), through specific growth factors, cytokines and small molecules69. Embryology has 
provided important insights into key pathways guiding hPSC fates, resulting in the efficient induction 
of ectoderm, mesoderm, and endoderm and many of their derivatives. The next challenge will be to 
address the functionality of these cells, both in vitro and in preclinical models70. 
Activin-Nodal and FGF signaling cooperate together to maintain human pluripotency71,72. 
Expression of BRACHYURY (T) is typically used to monitor the formation of a primitive streak-like 
population and the subsequent mesoderm induction. BMP4 induces the formation of a BRACHYURY+ 
primitive streak population as well as the later development of FLK-1+ mesoderm73. Conversely, 
blocking Wnt signaling at early stages of differentiation inhibits the formation of cells expressing 
BRACHYURY and mesoderm development, which demonstrates that this pathway is involved in the 
generation of the primitive streak and mesoderm74. However, other studies have reported that Wnt 
signaling is associated with self-renewal75. Activin-Nodal signaling induces a primitive streak 
population and the subsequent formation of mesoderm and endoderm, according to the strength of the 
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signal76. In contrast, inhibition of BMP4, Wnt and Activin signaling leads to an anterior neural-fate 
acquisition in the dorsal ectoderm, providing the basis of the ‘default’ model of neural induction. In the 
ventral ectoderm, where the signaling ligands escape the inhibitors, an epidermal fate is induced34. 
Following inhibition, if cells are subsequently induced by FGF, they will generate neurons, since FGF-
ERK signaling has been shown to inhibit BMP signaling, thereby promoting neural differentiation34. 
 
Fig. 1.2 Inducing pluripotent stem cell differentiation into cardiac mesoderm, hepatic endoderm, and neuroectoderm 
derivatives. 
Schematic representation demonstrating the main relationships between cardiac, hepatic and neural cell lineages, 
sublineages, marker expression, and signaling pathways governing each cell type. When PSC are induced with Wnt, 
Activin A or BMP4, these cells will form a primitive streak-like population, and subsequently mesoderm or endoderm. 
If these pathways are not activated, PSC will differentiate into ectoderm. The differentiation of hiPSC into neurons 
transit through intermediate stages that resemble the neural stem cells (NSC) in vivo. hiPSC differentiate into neural 
progenitor/neuroepithelial stem cells that correspond to the NSC that form the neural plate in vivo. During in vivo 
neurulation, the neural tube closes, patterning along the developmental axes occurs, and the first types of neurons are 
generated. The correspondent step in vitro is the formation of neural rosettes that will give rise to neurons and glia. 
From primitive streak induction, the posterior primitive streak cells generate FLK-1+ mesoderm, followed by the 
formation of cardiac mesoderm and cardiac progenitors that will give rise to differentiated cells. Alternatively, the 
anterior primitive streak cells may be induced by Activin/Nodal and form FOXA2+ definitive endoderm, followed by 
the generation of hepatoblasts and hepatocytes. Abbreviations: FHF, first heart field; SHF, second heart field; EPDCs, 
epicardium-derived cells; EMT, endothelial-to-mesenchymal transition; SAN, sinoatrial node; RBB, right bundle 
branch; LBB, left bundle branch; PF, purkinje fibers; AV, atrioventricular. (Adapted from Gordillo et al., 2015; Später 
et al., 2014; Murry and Keller, 2008). 
 
1.6.1 Commitment Towards Neuroectoderm 
One of the most efficient ways to differentiate hPSCs towards neural commitment is by dual SMAD 
inhibition of Activin/Nodal and BMP signaling, which belong to the TFG-β superfamily, obtaining 
neural progenitors (e.g. PAX6+ and OTX2+ cells),  capable of originating neurons (e.g. β-Tubulin III+, 
MAP-2+, NeuN+ and TUJ1+ cells), and astrocytes (GFAP+ cells)77. The TGF-β family is therefore crucial 
for the maintenance of hiPSCs pluripotency and self-renewal, as well as for the differentiation into 
mesendoderm78. Moreover, Wnt signaling is associated with the promotion of neural crest formation in 
embryonic development and its continuous activation by GSK3β inhibition and Activin A signaling 
inhibition focus neuroectoderm commitment into neural crest cell derivation79.  
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1.6.2 Commitment Towards Mesendoderm 
Activin, BMP and Wnt signaling are associated with the induction of mesendoderm regulators, like 
BRACHYURY, EOMES and MIXL180. These precursors can further differentiate into FLK1+ 
mesoderm progenitors or FOXA2+ endoderm progenitors81. At this point, a thin balance between 
mesoderm and endoderm exists, and Activin A stimulation leads to a FOXA2+ population of definitive 
endoderm, especially if PI3K signaling is suppressed82,83. Conversely, BMP inhibits paraxial mesoderm 
formation and promotes lateral plate mesoderm specification84. Furthermore, Lian et al have 
demonstrated that the modulation of Wnt/β-catenin signaling directs cardiomyocyte (CM) 
differentiation from hPSC. Thereby, the authors reported that using B27 without insulin and inducing 
the sequential activation of canonical Wnt signaling by GSK3 inhibitor treatment, followed by inhibition 
of Wnt signaling by small molecules (IWPs) (GiWi protocol), is sufficient to drive multiple hPSC lines 
to CMs85. Therefore, specification of nascent BRACHYURY+ mesodermal progenitors towards a 
cardiogenic fate requires inhibition of canonical Wnt/β-catenin signaling and activation of noncanonical 
Wnt signaling, promoting also the differentiation of those cardiac progenitors86. Moreover, evidence has 
shown that insulin, present in B27 supplement, strongly inhibits CM yield during the first 5 days of 
differentiation85. 
Overall, these observations show that the usual regulatory pathways control self-renewal and 
multiple stages of commitment, in a time, dose and cell-dependent context, modulating the stimulation 
or inhibition of lineages specification. 
 
1.7 Transcriptomic Analysis by RNA-Sequencing 
The transcriptome is the complete set of transcripts present in a cell, and their quantity, for a specific 
physiological condition or developmental stage. Recently, the development of novel high-throughput 
sequencing methods, namely RNA-Sequencing (RNA-Seq) has enabled both mapping and quantifying 
transcriptomes. The main objectives of this approach are: to catalogue all types of transcripts, including 
mRNAs, non-coding RNAs and small RNAs; to analyse the transcriptional structure of genes, in terms 
of their start sites, 5′ and 3′ ends, splicing patterns and other post-transcriptional modifications; and to 
quantify the differential expression levels of each transcript during development and under different 
physiologic conditions87. In addition, RNA-Seq can be implemented without prior knowledge of the 
reference or sequence of interest and provides multiple applications such as: ‘de novo’ reconstruction 
of the transcriptome (without a reference genome). Also, this technology presents some advantages over 
the cDNA microarrays, such as the high level of data reproducibility and reducing the number of 
technical replicates for the experiments88. 
A typical RNA-Seq experiment is summarised in Fig. 1.3. Generally, RNA is extracted and a 
population of RNA, total or fractionated, such as poly(A)+, is converted to a library of cDNA fragments 
with adaptors attached to one or both ends. Each molecule, with or without PCR amplification, is then 
sequenced in a high-throughput sequencing technology to obtain short sequences from one end (single-
end sequencing) or both ends (pair-end sequencing). The reads are usually 30–400 bp, depending on the 
sequencing technology used87. Theoretically, any high-throughput sequencing technology can be used 
for RNA-Seq, such as the Illumina IG89, Applied Biosystems SOLiD90 and Roche 454 Life Science91 
systems, which have already been performed for this purpose. 
Global transcriptomic analysis has provided new ways to explore heterogeneous and rare 
subpopulations, including samples with a low number of cells, circumventing limitations associated with 
investigating early human development and stem cell biology92. This method provides us with new 
insights about developmental biology, and particularly, stem cell fate decisions.  
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Fig. 1.3 A typical RNA-Seq experiment. 
Briefly, mRNA is extracted and converted into a library of cDNA fragments through either RNA fragmentation or DNA 
fragmentation. Sequencing adaptors are subsequently added to each cDNA fragment and a short sequence is obtained 
from each cDNA using high-throughput sequencing technology. The resulting sequence reads are aligned against the 
reference genome or transcriptome and classified as three types: exonic reads, junction reads and poly(A) end-reads. 
These three types are used to produce a base-resolution expression profile for each gene, as illustrated at the bottom; a 
yeast ORF with one intron is shown. (Adapted from Wang et al., 2009). 
2 Aim of Studies 
Investigating the regulatory mechanisms underlying cell fate decision and subpopulation specification 
is fundamental for a better understanding of early human development, which cannot be interrogated in 
vivo due to restrictions on human embryo studies. This knowledge might one day be exploited for 
regenerative medicine, disease modeling and drug discovery fields. However, the regulatory 
mechanisms underlying hPSC differentiation into specific lineages remain elusive. Such need represents 
the motivation for initiating this study and its overall goal is to reproduce and analyse robust processes 
for the differentiation of hPSC. 
Hence, this work aims to use hiPSC as in vitro model systems to analyse their controlled 
differentiation into specific homogeneous cell types. We aim to delineate a representative roadmap for 
early human development and reconstruct the differentiation trajectories by which pluripotent cells 
sequentially elaborate a diversity of neuroectodermal, cardiac mesodermal and hepatic endodermal 
progeny. Tracking these three-germ layer-derived divergences uncovers the sequential molecular events 
that ultimately lead to the establishment of different cell types.  
Furthermore, we aim to provide a comprehensive study through transcriptomic and network 
modeling approaches, based on RNA-Seq data, to unveil the key signaling pathways and gene 
expression profiles that efficiently induce each of these lineages at sequential stages. We expect to 
perform this at a global gene expression level, and then focusing solely on genes encoding TFs, since 
these modulate a broad regulatory network orchestrating gene expression programs that elicit different 
cell responses.  It is also expected to possibly predict novel key developmental regulators with few or 
no prior literature reports. 
Overall, this study aims to contribute to the analysis of well-established cell culture models that 
better reflect in vivo function, presenting new insights that can be harnessed for optimization of 
differentiation protocols. Hence, we expect to provide important information regarding the mechanisms 
10 
 
that control hPSC fate transitions, with implications for understanding trans-lineage differentiation for 
stem cells, developmental cell biology and regenerative medicine. 
3 Materials and Methods 
3.1 Data Analysis Workflow  
The data analysis pipeline used in this study is shown in Fig. 3.1. Thereby in the first task (prediction of 
lineage specifiers), we intended to expand our original gene database, containing genes sorted by their 
involvement in each specific germ-layer commitment. To that aim, we performed a database review 
through the resource Genome (NCBI) to identify human genes previously reported in the literature as 
being involved specifically in each germ layer commitment. For further validation, we found that these 
three distinct groups of selected genes from NCBI were enriched for the expected Gene Ontology (GO) 
terms. Therefore, ectoderm-associated gene results were predicted as being significantly overexpressed 
in ectoderm development (false discovery rate (FDR) of 4.16e-26); mesoderm-associated gene results 
were significantly enriched for mesoderm development (FDR of 5.04e-177); and endoderm-associated 
gene results were significantly related to endoderm development (FDR of 1.9e-57). Subsequently, these 
three groups of validated genes from NCBI were added to our previous/original gene database, in order 
to complete it with additional elements. In this way, we created a literature-based curation list of 
ectoderm, mesoderm and endoderm-associated gene clusters, which allowed us to expand our gene 
database to cover a higher number of specific germ layer-related genes (Supplementary Table 7.1, 
Supplementary Information). 
In the second task, we elaborated a clustering analysis of this resulting expanded gene database, 
through STRING platform, which predicts functional protein association networks, to analyse their 
associated biological processes and signaling pathways enrichment (Fig. 4.1 and Supplementary Table 
7.2).  
The third task consisted of RNA-Seq data processing and network analysis of hPSC differentiation 
into specific cell types, particularly into neurons, CM and hepatocytes. This task was furtherly split into 
two sub-tasks: a first analysis that was based on global gene expression, and a second analysis focused 
solely on genes encoding TFs. The first sub-task comprised data normalization, clustering techniques 
such as heatmaps and PCAs (Principal Component Analysis), and Venn diagrams, together with GO 
enrichment of RNA-Seq gene expression. The second sub-task allowed us to identify genes encoding 
TFs guiding hPSC towards ectodermal, mesodermal and endodermal specification (Supplementary 
Table 7.3 and Supplementary Fig. 7.2).  
 
Fig. 3.1 Data analysis workflow.  
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Data analysis pipeline, from the gene prediction to clustering analysis, data processing and network analysis. 
Abbreviations: RNA-Seq, RNA-Sequencing; hPSC, human pluripotent stem cells; PCA, principal component 
analysis; GO, gene ontology; TFs, transcription factors. 
 
Then, data normalization, clustering techniques (Heatmaps, PCAs), Venn diagrams and literature review 
of the gene functions, together with GO enrichment of RNA-Seq gene expression were performed. This 
led us to identify novel putative regulators of cardiogenesis and neurogenesis, whose expression was 
validated by Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR). 
Overall, this pipeline contributed to a better understanding of the regulatory mechanisms 
underlying cell fate decisions in hPSC.  
 
3.2 Expansion of Human Pluripotent Stem Cells  
3.2.1 Cell Lines  
One of the hiPSC lines used in this work was WT- F002.1A.13 (TCLab - Tecnologias Celulares para 
Aplicação Médica, Unipessoal, Lda.), reprogrammed from fibroblasts obtained from a skin biopsy on 
an adult female. By using a retroviral system, the hiPSCs have been generated through ectopic 
expression of a defined set of reprogramming factors, Oct4, Sox2, Klf4 and c-Myc. The cell line has 
been tested in terms of differentiation potential towards the three germ layers, while the analysis revealed 
a normal karyotype. 
Another cell line used in this study was iPS-DF6-9-9T.B, provided by WiCell Bank (Wisconsin, 
USA). This cell line is vector free and was reprogramed from foreskin fibroblasts with a karyotype 46, 
XY that were collected from healthy donors using defined factors in the Laboratory of Dr. James 
Thomson, at University of Wisconsin.  
When referred, published datasets were used to complement our analysis, with the following cell 
lines: H9 and HES3 hESC lines (Meganathan et al., 2017)93; WA01 and HuES6 hESC lines (Frank et 
al., 2019)94; and Human H1 ES cells (Li et al., 2017)95. 
 
3.2.2 Cell Passaging  
As adhesion substrate, Matrigel® matrix (Corning®) was used. Aliquots were thawed on ice and diluted 
1:100 (v/v) in cold Dulbecco’s Modified Eagle Medium: Nutrient Mixture F-12 (DMEM/F12) 
(Gibco™/ Thermo Fisher Scientific). This formulation was used to coat culture plates (Corning®), that 
were left at room temperature at least for two hours or stored at 4ºC for later use up to 2 weeks. 
The WT- F002.1A.13 cell passaging was performed using an enzyme-free cell passaging with 
EDTA solution (Invitrogen™/ Thermo Fisher Scientific) diluted in phosphate-buffered saline (PBS) at 
a concentration of 0.5 mM. This method allows the detachment of hiPSCs colonies into small 
aggregates. After culture medium removal, cells were washed twice and then incubated with EDTA at 
room temperature for 5 min. After EDTA removal, cells were flushed with culture medium (essential 
8TM medium) (E8) (Gibco®) and collected to a centrifuge tube followed by seeding onto new Matrigel® 
coated culture plates. Splits 1:3 were performed. 
The iPS-DF6-9-9T.B cell passaging was performed by the same method, excluding the culture 
medium (mTeSR1™ medium) (STEMCELL Technologies™). In contrast with the mTeSR1 medium, 
which has 18 components added to DMEM/F12 base medium, E8 contains only 8 essential components 
and is a completely defined medium, without bovine serum albumin (BSA), but presenting a similar cell 
expression pattern when compared to mTeSR1 medium96. 
When referred, published datasets were used to complement our analysis and cells were expanded 
as previously described93-95. 
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3.3 Differentiation Protocols 
To obtain samples for RNA-Seq, neuronal differentiation of hiPSC was performed by a PhD student 
from our group97, based on dual-SMAD inhibition protocol77. Briefly, human neural progenitor cultures 
were passaged at day 12 by using EDTA dissociation buffer (0.5 mM), and were re-plated in a split ratio 
of 1:1 into poly-L-ornithine (15 μg/mL; Sigma)-treated and Laminin (20 μg/mL, Sigma) coated plates. 
At day 14, when structures like neural rosettes were observable, N2B27 medium was supplemented with 
bFGF-Basic fibroblast growth factor (10 ng/mL, Peprotech) during 48h. At day 16, cells were again 
passaged by using EDTA, into new laminin-coated wells, in a split ration of 1:3. The medium was 
changed daily, without the addition of any small molecule or factor. At day 28, cells were split with 
accutase and plated into laminin-coated wells at a density of 100.000 cells/cm2. The N2B27 medium 
was replaced every two days until day 70. When referred, a published dataset by Meganathan et al93 was 
used to complement our analysis and accordingly, neuronal differentiation of hESC was performed as 
previously described93. Thereby, cortical excitatory and inhibitory neuronal differentiation was 
performed by modification of prior protocols98,99. 
To obtain samples for RNA-Seq, hiPSC-CM differentiation was performed by a PhD student from 
our group100, based on the Wnt signaling modulation protocol previously described by Lian et al85, using 
6 μM of the GSK3b inhibitor CHIR99021 (Stemgent) at day 0 and 5 μM of the Wnt signaling inhibitor 
IWP4 (Stemgent) at day 3. Cells were seeded onto Matrigel® coated 12-well tissue culture plates 
(Corning®) at a cell density of 4x105 cells/well for a final volume of 1 mL/well (1x105 cells/cm2). 
Culture medium was changed daily until a confluence of 90%-95% was achieved.  
In addition, cardiac differentiation was also performed after RNA-Seq, for subsequent downstream 
analysis (by qRT-PCR and flow cytometry), as explained in sections 3.5 and 3.6, respectively. When 
referred, a published dataset by Frank et al was used to complement our analysis, whereby hESC-CM 
differentiation was performed as previously described94,101.  
When referred, a published dataset by Li et al was used to complement our study, providing us with 
additional RNA-Seq data that we analysed, whereby hESC-hepatocyte differentiation was achieved as 
previously described95. 
 
3.4 Transcriptomic Analysis by RNA-Sequencing  
3.4.1 Sample Collection and RNA Extraction 
Prior RNA isolation, cell samples from sequential stages of cardiac and neuronal differentiation were 
collected by students from our group, in the context of their PhD thesis, respectively97,100.  
RNA samples were isolated in triplicates from each of the selected time points. Total RNA from the 
samples was extracted using High Pure RNA Isolation Kit (Roche, Cat. 11828665001), according to 
manufacturer´s instructions. 
 
3.4.2 RNA-Seq Sample Preparation and Sequencing 
RNA libraries were prepared for sequencing using Lexogen QuantSeq 3'mRNA-Seq Library Prep Kit 
FWD for Illumina using standard protocols. Briefly, 500 ng of total RNA were primed with the oligo 
dT primer containing Illumina-compatible linker sequences. After first strand synthesis, the RNA was 
removed, and the second strand synthesized with Illumina-compatible random primers. After magnetic 
bead-based purification, the libraries were PCR amplified introducing the sequences required for cluster 
generation. Sequencing was performed using HiSeq (50 cycles protocol) or NextSeq (75 cycles 
protocol) platforms. Sequencer Software HiSeq Control Software 2.2.58 was used for base calling of 
samples processed on Illumina HiSeq 2000. Base calling of samples processed in NextSeq Sequencer 
was performed with the Real-Time Analysis (RTA) v2. 
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3.4.3 RNA-Seq Data Analysis 
Sample read quality, reads mapping and counting were performed by a standard protocol from BlueBee 
Genomics Platform (http://www.bluebee.com/). 
 
3.4.4 Datasets  
The datasets used in this study were derived from RNA-Seq of sequential stages of CM and neuronal 
differentiation (as described in 3.2-3.4 sections). In addition, when referred, published RNA-Seq 
datasets were used to complement our analysis (from neural, cardiac, and hepatic fetal and adult cell 
types), as summarized in Supplementary Table 7.4; and (from neural, cardiac and hepatic 
differentiations) in Supplementary Table 7.5. 
 
3.4.5 Differential Gene Expression Analysis 
With the RNA-Seq read counts matrix, we then used the DESeq2 package of R (version 3.5.1) to perform 
data normalization and differentially expressed genes (DEGs) analysis. Information about DESeq2 
package is available online at https://bioconductor.org/packages/release/bioc/html/DESeq2.html. 
 
3.4.6 Bioinformatic Analysis of Transcriptomes 
In order to analyse both global gene expression and solely genes encoding TFs, several approaches were 
performed. PCA was used to determine whether samples display greater variability between 
experimental conditions than between replicates of the same treatment. Therefore, plots were used to 
visualize gene expression values in two dimensions, representing the two principal components, that is, 
the two orthogonal directions of the data with the highest variance102.  
Expression heatmaps were designed as a visualization tool of patterns and relationships among high 
dimensional transcriptomic data. Both PCA and expression heatmaps were performed using ClustVis 
(http://biit.cs.ut.ee/clustvis), a web tool for visualizing clustering of multivariate data (BETA)103. These 
plots were created from read counts normalization to counts per million (CPM), or fold-change > 2. 
Venn diagrams were created manually and used as a method to visualize complex genetic set 
relations, to compare multiple transcriptomic datasets and to identify the number of DEGs in each 
condition. The size of circles and areas was designed proportionally to the number of elements included. 
To identify TFs guiding hPSC towards ectodermal, mesodermal and endodermal specification, 
genes encoding TFs were screened, according to their log2(CPM), for each of the selected common 
timepoints between three types of differentiation datasets (at days 0, 1, 3 and 9). Genes encoding TFs 
were then identified in scatter plots (Supplementary Fig. 7.2), to compare the correlation/proximity 
between the expression of these TFs in each germ layer commitment. Subsequently, we performed a 
literature review of their previously described gene functions to confirm their role in the determined 
differentiation process, or to ascertain if some of them had no or few prior literature reports (data not 
shown). 
For the whole transcriptomic analysis by RNA-Seq, significantly DEGs were selected based on the 
following cutoff: adjusted p-value < 0.05 and fold-change > 2.  
 
3.4.7 Clustering Analysis - STRING Protein-Protein Associations and Gene Ontology Enrichment 
Analysis 
GO terms were identified using the PANTHER (protein annotation through evolutionary relationships) 
classification system (version 13.1)104. GO terms were identified by analysing DEGs using the following 
settings: GO Biological Process, test type FISHER, reference list Homo Sapiens and FDR<0.05. Non-
redundant GO enriched terms were selected and plotted using Corrplot package from R. 
The STRING database (https://string-db.org/) was used to extract well-curated interactions between 
protein encoding genes that were identified in our transcriptomic analysis. This allowed us to construct 
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a regulatory network of known and predicted protein–protein interactions and to assess their enriched 
biological processes and signaling pathways. The network was clustered into groups of genes sharing 
similar profiles and cluster positions were determined by an algorithm based on global confidence 
binding score. Proteins were then clustered applying the Markov Cluster Algorithm (MCL), with an 
inflation parameter = 3 (which controls the granularity of clustering). Additionally, when referred, 10 
more proteins were predicted for the networks. 
 
3.5 Quantitative Real-Time Polymerase Chain Reaction 
Total RNA from cell samples of sequential stages of CM differentiation was extracted using High Pure 
RNA Isolation Kit following the provided instructions. RNA was quantified using a nanodrop and 1 μg 
of RNA was converted into cDNA with High Capacity cDNA Reverse Transcription Kit (Applied 
Biosystems™/ Thermo Fisher Scientific) also following the provided instructions. PCR reactions were 
run using SYBR Green PCR master mix. The list of primers used is in Supplementary Table 7.6. 
Reactions were run in triplicate using ViiA™ 7 Real-Time PCR Systems (Applied Biosystems™/ 
Thermo Fisher Scientific) and data was analysed using QuantStudio™ Real-Time PCR Software 
(Applied Biosystems™/ Thermo Fisher Scientific). The analysis was performed using the ΔΔCt method, 
therefore expression is always represented as relative to day 0 and normalized against the expression of 
the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH). 
For neuronal differentiation, we used previously harvested cDNA at sequential stages of 
differentiation and we directly performed qRT-PCR using those samples. 
 
3.6 Flow Cytometry 
For flow cytometry, differentiated CM on day 15 were collected. After culture medium removal, cells 
were washed with PBS and then incubated with 0.25% (v/v) trypsin-EDTA (Gibco™/ Thermo Fisher 
Scientific) in PBS, at 37ºC for 7 min. Then, to inactivate enzymatic activity, culture medium was added 
and cells were collected and centrifuged at 200 xG for 3 min. Cell pellet was washed with PBS and 
centrifuged again and after supernatant removal, cell pellet was fixed with 2% (v/v) paraformaldehyde 
(PFA) reagent (Sigma-Aldrich®/ Merck) in PBS, and stored at 4ºC until flow cytometry. 
 
3.6.1 Cardiac Troponin T 
Fixed cells were centrifuged at 200 xG for 3 min. Cell pellet was resuspended and incubated with 90% 
(v/v) cold methanol in Milli-Q® water at 4ºC for 15 min. Cells were then washed 3 times with flow 
cytometry buffer 1 (FB1), constituted by 0.5% (v/v) bovine serum albumin (BSA) solution (Sigma-
Aldrich®/ Merck) in PBS, and centrifuged at 200 xG for 3 min, each time. Cell pellet was resuspended 
and incubated in the primary antibody mouse IgG anti-cTnT (Invitrogen™/ Thermo Fisher Scientific) 
diluted 1:400 (v/v) in FB2, constituted by 0.1% (v/v) Triton X-100 (Sigma-Aldrich®/ Merck) in FB1, 
at room temperature for 1 h. After incubation, cells were washed with FB2 and cell pellet was 
resuspended and incubated in the secondary antibody Alexa Fluor™ 488 goat anti-mouse IgG 
(Invitrogen™/ Thermo Fisher Scientific) diluted 1:1000 (v/v) in FB2, at room temperature for 30 min 
in the dark. Cells were washed twice with FB2 and centrifuged at 200 xG for 3 min, each time. Cell 
pellet was resuspended in FB1 for a final volume of 300 μL/FACS tube. Flow cytometry was performed 
using a FACSCalibur™ flow cytometer (Becton Dickinson) and data analysis using Flowing Software 
2.0. 
4 Results and Discussion 
4.1 In Silico Analysis – Prediction of Lineage Specifiers 
In order to assess hPSC fate transitions, a systematic in silico analysis was performed to predict which 
genes (Supplementary Table 7.1) and associated biological processes and/or signaling pathways have 
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been reported as playing an active role during specific early differentiation events. Therefore, we 
expanded our original gene database and created a literature-based curation list of ectoderm, mesoderm 
and endoderm-associated gene clusters. This approach was used to map a cellular landscape for early 
lineages and decisions, exhibiting heterogeneous patterns of differentiation connected to multiple 
biological responses (Fig. 4.1 and Supplementary Table 7.2). These responses alternated from 
generalized developmental processes involved in whichever fate, to germ layer-particular events, such 
as forebrain and telencephalon regionalization, in ectodermal-related genes; or heart development, in 
mesodermal-related genes. This suggests the existence of gene clusters commonly activated throughout 
any continuing differentiation process, while others correspond to lineage-specific regulated events, that 
may be induced in a transient state during commitment of pluripotent cells to a particular lineage, which 
is consistent with previous evidence105. Moreover, the size of each sub-cluster gives us indications about 
the number of predicted protein-protein interactions enriched expression.  
 
Fig. 4.1 Gene network clustering analysis. 
Each cluster color represents a protein-protein interaction network prediction based on protein encoding genes curated 
from literature, known to be involved in human ectodermal, mesodermal and endodermal specification. These 
interaction networks were obtained by STRING database, that predicts associations based on in vivo and in vitro 
experimental assays. Proteins (nodes) were clustered using the Markov Cluster Algorithm (MLC) with an inflation 
parameter = 3. 10 more proteins were predicted for the network. This figure highlights the biological processes (FDR < 
0.05) associated to the analysed proteins. Additional biological processes were predicted for each sub-cluster of proteins, 
but were here excluded for simplification purposes. 
 
4.2 RNA-Seq Data Analysis of hPSC Differentiation into Specific Cell Types 
To perform a transcriptomic analysis, we first sought to discriminate different stages of differentiation 
and to compare the level of in vitro differentiation derived from our protocols with in vivo human 
development. Therefore, we compared the RNA-Seq gene expression profiles of hiPSC-derived neurons 
(hiPSC-Neurons) with the transcriptomic profiles of human fetal and adult brain tissues; and of hiPSC-
derived CM (hiPSC-CM) with human fetal and adult heart tissues (datasets information provided in 
Supplementary Table 7.4). Additionally, fetal and adult liver gene expression is shown, however until 
now, we have not yet sequenced our hiPSC-derived hepatocytes, which would therefore be useful for a 
broader comparative analysis. For that reason, our whole subsequent transcriptomic analysis will be 
mainly particularized to the ectodermal and mesodermal lineages. 
As shown in Fig. 4.2, Principal Component Analysis (PCA) clearly distinguished the samples from 
different stages, with fetal, adult and differentiated cells forming distinct groups in all three 
differentiations (neural, cardiac and hepatic). Principal Component 1 (PC1) relates to differentiation 
progression, with the differentiated cells presenting the lowest degree of differentiation, the adult tissues 
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exhibiting the highest, and the fetal tissues with intermediate levels, consistent with previous data106-108. 
This indicated a robust directional differentiation. The only exception was between the fetal and adult 
heart (Fig. 4.2 C), which could be explained by cellular heterogeneity due to different cell types specified 
among datasets. Moreover, most differentiated cells, fetal, and adult samples clustered in well-defined 
“groups”, although a subpopulation of cells from fetal liver exceptionally presented divergencies 
between replicates. Importantly, all three replicates from either differentiated CM (Fig. 4.2 C) or 
differentiated neurons (Fig. 4.2 A) clustered together, demonstrating no or few divergencies of our gene 
expression results, further validating our cardiac and neuronal differentiation methods. 
 
 
Fig. 4.2 Comparison of in vitro and in vivo expression profiling. 
Principal component analysis for RNA-Seq gene expression, from reads normalization in counts per million. X and Y 
axis show principal component 1 (PC1) and principal component 2 (PC2) that explain (A) 45.9% and 27.1%, (B) 72.5% 
and 11.7%, and (C) 53.2% and 18.9% of the data set total variance, respectively. For fetal brain, n=1 and for all others, 
n=3. 
 
Furthermore, we sought to compare our neuronal and cardiac differentiation protocols with distinct 
protocols to obtain the same desired cell types, although using different cell lines, differentiation factors 
and/or culture mediums to obtain them. Schematic of the protocols and stages of differentiation is 
depicted in Fig. 4.3A, B, D and E. In addition, a dataset from a hepatic differentiation protocol (Fig. 
4.3G) and the resulting PCA (Fig. 4.3H) is shown. These variations in the protocols implied a distinct 
modulation of the signaling pathways and gene expression patterns that regulated stem cell fate 
decisions. We found that besides those differences, the PCA plot showed that distinct groups appeared 
in chronological order, clearly distinguishing the samples from different stages and we were able to 
define the lineage trajectories (Fig. 4.3C, F and H). In both neuronal and cardiac differentiation, 
Principal Component 2 (PC2) relates to differentiation progression, whereas in the hepatic 
differentiation, PC1 relates to it, indicating a robust directional differentiation. The arc connecting these 
experimental groups can therefore be regarded as a representative description of the differentiation track 
by gene expression changes. This allowed us to successfully validate our differentiation efficiency with 
the comparative gene expression analysis with other in vivo and in vitro types of differentiation.  
To conclude this analysis, we present an overview of the intersecting DEGs between those states, at 
sequential stages of both differentiations (Supplementary Fig. 7.1).  
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 Fig. 4.3 Global gene expression profiling of human pluripotent stem cell fate transitions.  
(A) Schematic of the protocol and stages of hiPSC-Neurons by our group. (B) Schematic of the protocol and stages of 
hESC-derived cortical interneurons, by Meganathan et al., 2017. (C) Principal component analysis (PCA) indicates the 
transitions that occur during neuronal differentiation. X and Y axis show principal component 2 (PC2) and principal 
component 1 (PC1), that explain 18.9% and 48.7% of the data set total variance, respectively. (D) Schematic of the 
protocol and stages of hiPSC-CM, by our group and (E) of hESC-derived CM by Frank et al., 2017, respectively. (F) 
PCA indicates the transitions that occur during cardiac differentiation. X and Y axis show PC2 and PC1, that explain 
18% and 52.3% of the data set total variance, respectively (G) Schematic of the protocol and stages of hESC-derived 
hepatocytes, by Li et al., 2017. (H) PCA indicates the transitions that occur during hepatic differentiation. X and Y axis 
show PC1 and PC2, that explain 44.6% and 19% of the data set total variance, respectively. PCAs were generated from 
reads normalization in counts per million. For all cardiac and neuronal differentiations, n=3. For hepatic 
differentiation, n=1. Abbreviations: hiPSC, human induced pluripotent stem cells; NPs, neural progenitors; NSC, 
neural stem cells; hESC, human embryonic stem cells; hiPSC-CM, hiPSC-derived cardiomyocytes; EBs, embryoid 
bodies; MGE, medial ganglionic eminence; Asc. acid, ascorbic acid; OSM, oncostatin M. 
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4.3 Key Transcription Factors in the Differentiation of hPSC 
The differentiation of hPSC into specific cell types is controlled by several cytokines, growth factors, 
extracellular matrix molecules and TFs69. The activation of TFs may have important effects, such as the 
concomitant upregulation of genes and signaling pathways responsible for the induction and progression 
of cell type-specific differentiation109. Therefore, in this section, we intended to identify master TFs that 
regulate the expression of other genes, to critically discuss and evaluate their roles in the differentiation 
of hPSC toward neurons, CM and hepatocytes. 
In order to assess hPSC fate transitions, first, we performed a systematic RNA-Seq expression 
analysis to identify which statistically significant upregulated genes encoding TFs played an active role 
guiding hPSC towards mesodermal and ectodermal specification, at sequential stages of differentiation 
(Supplementary Table 7.3).  
Then, we sought to analyse the expression of key TFs governing different stages of differentiation. 
Therefore, we compared the RNA-Seq gene expression profiling of three germ layer-derived cell types, 
namely hiPSC-CM, hiPSC-Neurons, and hESC-derived hepatocytes, at common sequential stages of 
differentiation. To that aim, we selected all genes coding TFs and generated a PCA to visualize the 
differentiation trajectories of hPSC (Fig. 4.4).  
PCA clearly distinguished the neuroectodermal, cardiac mesodermal and hepatic endodermal fates, 
as revealed by well-defined lineage divergences that emerged early in the differentiation process, soon 
after exiting pluripotency (day 0). Notably, at day 0, the expression results of ectoderm differentiation 
were closer to those of mesoderm, than to those of endoderm differentiation. This could be due to 
differences among the cell lines, especially from those employed in the external published hepatic 
dataset analysed in this study (using hESC instead of hiPSC), although all represent pluripotent cells at 
that state. Overall, PCA indicates that there are considerable differences between all types of 
differentiation, due to distinct networks of TFs governing specific cell types. Therefore, from 
pluripotency, cells navigate through germ layer specification, comprising three transcriptionally distinct  
 
Fig. 4.4 Human pluripotent stem cell fate transitions.  
(A) Schematic of the neuronal, cardiac and hepatic in vitro differentiation. RNA-Seq gene expression from highlighted 
days of differentiation (light blue) was analysed. (B) Principal component analysis for RNA-Seq gene expression, from 
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reads normalization in counts per million. X and Y axis show principal component 1 (PC1) and principal component 2 
(PC2), that explain 23.4% and 29.2% of the data set total variance, respectively. PC1 corresponds to differentiation 
progression and PC2 relates to cell fate decision.  For ectoderm and mesoderm, n=3; for endoderm, n=1 (published 
dataset from Li et al., 2017). (C) Bright-field image of neural rosettes on day 15 of differentiation (D) Bright-field image 
on day 34 of neuronal differentiation. (E) Bright-field image of cardiomyocytes on day 15 of differentiation. 
Abbreviations: D, day. 
 
subpopulations. PC1 relates to differentiation progression, which increases along time; and PC2 relates 
to cell fate decision, either ectodermal, mesodermal or endodermal. As stated before, the arc connecting 
these experimental groups can therefore be regarded as a representative description of the differentiation 
track by gene expression changes. 
Subsequently, we focused our transcriptomic analysis particularly on ectodermal and mesodermal 
specification, in order to identify genes encoding TFs that were specifically up/down-regulated in each 
one of these two-germ layer differentiation, or commonly up/down-regulated between both germ layers 
commitment. Furthermore, we complemented this analysis with a GO analysis of DEGs (Fig. 4.5) for 
each type of differentiation. Expression heatmaps yielded four clusters of genes that were synchronously 
upregulated in both ectoderm and mesoderm differentiation (Fig. 4.5A), and then selected for GO 
analysis (Fig. 4.5B); and three clusters of genes that were simultaneously downregulated in both 
differentiations (Fig. 4.5C), and then selected for GO analysis (Fig. 4.5D). In addition, heatmaps 
depicting genes that were mutually exclusive upregulated (Fig. 4.5E) or downregulated (Fig. 4.5G) in 
either differentiation is shown, with the respective GO analysis of DEGs at sequential stages (Fig. 4.5F 
and H, respectively). 
 
Fig. 4.5 Expression profile of transcription factors encoding genes at sequential stages of neuroectoderm and cardiac 
mesoderm differentiation. 
(A) Heatmap comparing the expression of common upregulated genes between neuroectoderm and cardiac mesoderm 
differentiation, (B) and their respective clusters (highlighted in blue) were selected for Gene Ontology (GO) enrichment 
analysis. (C) Heatmap comparing the expression of common downregulated genes between neuroectoderm and cardiac 
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mesoderm differentiation, (D) and their respective clusters (highlighted in blue) were selected for GO enrichment 
analysis. (E) Heatmap comparing the expression of non-common upregulated genes between neuroectoderm and 
cardiac mesoderm differentiation, (F) and their respective GO enrichment analysis. (G) Heatmap comparing the 
expression of non-common downregulated genes between neuroectoderm and cardiac mesoderm differentiation, (H) 
and their respective GO enrichment analysis. In heatmaps, genes are displayed on the vertical axis, with the different 
time points on the horizontal axis. High expression levels are in dark green and low expression levels are in dark 
magenta. Heatmap shows average values from n=3 experiments for each time point. The color in the heatmap represents 
the log2 (fold-change) of normalized expression values. For GO analysis, specific days or gene clusters without 
statistically significant results were not shown. Day 6 of ectoderm differentiation was compared to day 5 of mesoderm 
differentiation in order to obtain more early time points to analyse. Significantly DEGs were selected based on the 
following cutoff: adjusted p-value < 0.05 and fold-change > 2. Abbreviations: E, ectoderm; M, mesoderm; D, day.    
 
Dynamic gene expression changes could be observed from day 3 until day 9 of either differentiation, 
generalized to all heatmaps. In particular, there were clusters of genes that were co-upregulated at the 
same time points in both differentiations, e.g. cluster 2 of Fig. 4.5A, upregulated at days 9 of both 
ectoderm and mesoderm differentiation. Thereby, from day 3 to day 9 of both differentiations (cluster 
4), there were sustained gene networks that led to an enrichment of GO terms related to development, 
cell fate commitment, cell differentiation, generation of neurons and regulation of Wnt signaling (Fig. 
4.5B). In a smaller temporal scale, particularly from day 5/6 to day 9 (cluster 3), there was an investment 
especially in hemopoiesis and circulatory system development-related processes. Specifically, at day 9 
(cluster 2), there was an upregulation of genes that led to an enrichment of GO terms related to 
development and differentiation. At day 5/6 (cluster 1) they appear related to a wide range of already 
stated biological processes, including specific signaling pathways, like BMP, Notch and Wnt as well.  
In addition, there were clusters of genes that were co-downregulated at the same time points for both 
differentiations (Fig. 4.5C), with GO terms related to endodermal cell fate specification from day 5/6 to 
day 9 (cluster 3, Fig. 4.5D), which is consistent with the establishment of ectodermal and mesodermal 
cell fate specification; and in cell differentiation, segmentation, morphogenesis and development, at day 
9 (cluster 2).  
Moreover, there were clusters of genes mutually exclusive upregulated at sequential stages of both 
differentiations (Fig. 4.5E). There was an enrichment of GO terms related to cell differentiation, system 
development, regionalization, telencephalon development, neuron fate commitment, etc. at days 6 and 
9 of ectoderm differentiation (cluster 1 and 2, Fig. 4.5F); while processes such as tube, circulatory 
system, and heart development, regionalization, etc. were enriched during mesoderm differentiation 
(clusters 3-7). As expected, cardiac-related processes such as mesoderm formation, heart and circulatory 
system development appeared much more enriched during cardiac differentiation than during neuronal 
differentiation, especially in cluster 6 (from day 3 to 9). Similarly, neural-related processes such as 
neuron fate commitment and telencephalon development were more enriched during neuronal than 
during cardiac differentiation, especially in cluster 2, the later ectoderm analysed time point. These data 
indicate an efficient discrimination of GO terms in each differentiation type. During CM differentiation, 
there are known markers of mesoderm, such as T, TBX6, MESP1/2110-112, that were upregulated from 
day 1 to day 5 (clusters 3-5). Coding genes for cardiac progenitors markers such as Islet-1, NKX2−5, 
TBX5 and GATA-4113-115, were also upregulated at day 9 of cardiac mesoderm differentiation (cluster 7). 
Similarly, during neuronal differentiation, coding genes for neural progenitors markers such as LHX5, 
PAX6 and SOX1116,117 were upregulated at day 9 of neuroectoderm differentiation (cluster 2).  
Finally, there were clusters of genes that were mutually exclusive downregulated at sequential stages 
of both differentiations (Fig. 4.5G), for GO terms related to developmental process and cell 
differentiation, especially at later time points, suggesting that there is a greater investment in these 
processes at earlier time points of differentiation (Fig. 4.5H). As expected, cardiac-related processes 
such as cardiac muscle hypertrophy in response to stress, circulatory system and heart development were 
downregulated during neuroectoderm differentiation; and BMP and Wnt signaling pathways were 
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downregulated at day 3 of neuroectoderm differentiation, supporting the ‘default’ model of neural 
induction34. 
After comparing common and mutually exclusive gene clusters of either differentiation, we sought 
to summarize our analysis from a broader perspective. Hence, we were interested in distinguishing 
which biological processes were differentially enriched exclusively in each type of differentiation, or 
simultaneously in both, at sequential time points. To that aim, we selected a group of non-redundant 
processes, some of them generally associated with development, whereas others are particularly 
characteristic of each germ layer specification, to compare their differential enrichment throughout 
differentiation. Additionally, we applied the same method to ascertain which signaling pathways were 
regulating these differentiation processes (Fig. 4.6). 
Generally, there is an upregulation of gene networks that lead to an enrichment of GO terms related 
to developmental process and cell differentiation along time, which is more gradual during ectoderm 
than mesoderm differentiation. In particular, mesoderm development increased especially from day 1 to 
3 of mesoderm differentiation. Then, from day 3, cardiac mesoderm-related processes, such as heart 
development, appeared much more enriched, which is consistent with the addition of the small molecule 
IWP4 (Wnt inhibitor) at day 3 of differentiation, thus inducing cardiac mesoderm and blocking other 
mesodermal fates. In addition, liver and endoderm development was only associated with mesoderm 
differentiation, not ectoderm. This observation could be explained by an upregulation of mesendodermal 
regulators, since there is a transient common precursor cell population that gives rise to both mesoderm 
and endoderm (mesendoderm)63. In corroboration, evidence has shown that endoderm induces the 
formation of several mesodermal organs, such as notochord, heart and blood vessels. Accordingly, some 
mesodermal organs help specify the endoderm64, further supporting the observed correlations.  
 
 
Fig. 4.6 Gene ontology analysis of key regulators of ectoderm and mesoderm differentiation. 
Differentially expressed genes (DEGs) encoding transcription factors (TFs) in ectoderm and mesoderm differentiation 
were grouped into Gene Ontology (GO) categories (p-value < 0.05). These graphs represent the statistically significant 
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results for biological processes and signaling pathways at days 1, 3, 6 and 9 of ectoderm differentiation, and days 1, 3, 
5 and 9 of mesoderm differentiation. Day 6 of ectoderm differentiation was compared to day 5 of mesoderm 
differentiation in order to obtain more early time points to analyse. Non-statistically significant results from GO on the 
analysed time points were not shown. High enrichment levels are in orange and low enrichment levels are in pink. 
Significantly genes were selected based on the following cutoff: adjusted p-value < 0.05 and fold-change > 2. 
Abbreviations: D, day; E, ectoderm; M, mesoderm; E+M, common between ectoderm and mesoderm.  
 
Similarly, liver development was only enriched from day 5 of mesoderm differentiation, probably due 
to the same reasons. Conversely, several neuroectoderm-related processes appeared much more enriched 
during ectoderm differentiation, at distinct time points of differentiation. However, they were 
particularly enriched at later time points (i.e. day 9), when a significant enrichment is generally observed 
among multiple neural-related processes, such as the development of the central nervous system, 
forebrain, telencephalon, neuron, brain, etc. 
Some genes were downregulated at distinct time points between both differentiations with GO terms 
related to developmental process and cell differentiation. As stated before, this downregulation was 
especially observed at later time points. As expected, genes associated with mesoderm and cardiac-
related processes, such as mesoderm and heart development, were downregulated from day 3 to 9 of 
ectoderm differentiation. Similarly, genes involved in neural-related processes, such as neuron 
development, were downregulated at day 9 of mesoderm differentiation, further corroborating our 
analysis. Interestingly, genes related to endoderm development were downregulated as soon as day 3 of 
ectoderm differentiation; and from day 5 of mesoderm differentiation, probably in order to induce and 
maintain mesoderm instead of endoderm, from the mesendoderm state.  
Regarding the regulation of signaling pathways throughout differentiation, Hippo signaling was 
active in a sustained way during mesoderm differentiation. Indeed, this pathway has been shown to play 
important roles in skeletal and cardiac muscles, both derived from mesoderm differentiation118. 
Additionally, this pathway has been proven to regulate CM proliferation and heart size119. TGF-β was 
gradually active along mesoderm differentiation, from day 3 to 9, as expected, since mesoderm 
commitment can be achieved by Activin/NODAL and BMP signaling pathways120. Wnt signaling 
pathway was active at days 1 and 3 of mesoderm differentiation and was subsequently downregulated 
after the latter time point. This is consistent with our employed protocol to derive CM, using the GSK3b 
inhibitor CHIR99021, that stimulates Wnt activation at day 0, and then the Wnt signaling inhibitor IWP4 
at day 3 of differentiation121. Genes coding for TFs involved in MAPK signaling pathway were not 
upregulated. MAPK/ERK signaling has been shown to be involved in CM survival122. Remarkably, none 
signaling pathway played an active role during neuroectoderm differentiation, which corroborates the 
‘default’ model of neural induction. According to this model, inhibition of BMP4, Wnt and Activin 
signaling leads to a neural-fate acquisition34. 
To conclude this analysis, we present an overview of the intersecting DEGs encoding TFs, 
modulated at sequential stages of both differentiations (Supplementary Fig. 7.3). Overall, it is possible 
to assess the differential expression of key regulators governing the controlled differentiation of hPSC 
into specific cell types, particularly into CM and neurons. 
Taken together, these results demonstrate that we were able to compare and define the major gene-
expression changes of the key regulators accompanying the transition from a pluripotent to an 
ectodermal versus mesodermal state and to discriminate both populations in terms of biological process 
enrichment. 
After confirming that distinct networks of TFs regulate cell fate decisions, we sought to assess which 
particular TFs were mainly governing each of these specific lineage choices. Those TFs were then 
identified in scatter plots, to compare the correlation/proximity between the expression of these TFs in 
each germ layer commitment (Supplementary Fig. 7.2). Subsequently, we performed a literature review 
of their previously described gene functions to confirm their role in the determined differentiation 
process, or to ascertain if some of them had no or few prior literature reports (data not shown). We found 
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that some of them have already been reported as key lineage regulators, which our analysis has 
confirmed, whereas others have not, thus requiring further investigation. In sum, this strategy allowed 
us to efficiently discriminate TFs acting as key regulators of hPSC fate transitions, through the 
comparative analysis between ectodermal, mesodermal and endodermal-derived cell lineages. 
 
4.4 Prediction of Novel Regulators 
In order to fill the knowledge gap regarding the transcriptional regulation during early CM and neuron 
differentiation, we profiled dynamic transcriptional changes at sequential stages. Two high-throughput 
sequencing datasets were compared for each type of differentiation: one derived from differentiated cells 
by our group; and another from a reported work (detailed information in Supplementary Table 7.5). This 
strategy was used as a proof of concept to accurately investigate temporal changes in transcription, that 
have been determined and thus supported by both datasets, further validating our observations.  
   We first sought to perform a high-throughput screen for selected lineage-specific markers, to compare 
their expression at similar time points between both datasets: between our dataset and one obtained in 
the literature, for both neuronal and cardiac differentiation (Fig. 4.7A and 4.8A, respectively).  
Regarding neuronal differentiation, we selected the genes OTX2, SATB2, NESTIN, PAX6, MAP2, 
SOX1, VGAT and NKX2.1, since they are generally associated with early neural differentiation123. Their 
positive expression was assessed to validate each type of differentiation, since these markers must be 
expressed independently of differences among protocols. Although their significant expression has been 
successfully confirmed, some slightly different patterns of expression have arisen, probably due to 
differences in the differentiation protocols and cell lines used (Fig. 4.7A). Indeed, to differentiate hESC 
into cortical interneurons, the authors used ventral NPC medium to generate embryoid bodies with 
ventral telencephalic characteristics. Also, they used distinct differentiation factors, which modulated 
TGF-β, Wnt, Hedgehog and Notch signaling pathways. Conversely, to differentiate hiPSC into neurons, 
we used N2B27 medium and we added small molecules to modulate TGF-β signaling pathways, based 
on dual-SMAD inhibition protocol77. NKX2.1 has been reported to be expressed in the medial ganglionic 
eminence (MGE)124, which is consistent with a higher expression of this TF in the MGE-derived 
interneurons, in comparison with the hiPSC-Neurons. Also, at the neural tube stage, PAX6 is 
downregulated in the region that will become the ventral telencephalon, concomitant with the 
upregulation of NKX2.1 in this region125, which is corroborated by a lower expression of PAX6 and a 
higher expression of NKX2.1 in the hESC-derived cortical interneurons, compared with the hiPSC-
Neurons. Moreover, SATB2 expression was slightly higher in the hESC-derived cortical interneurons, 
as expected, since it represents a cortical tissue patterning marker126. Furthermore, neural progenitor cell 
markers, such as SOX1, NESTIN and PAX6123; neuronal markers, such as MAP2123 and OTX2127; and 
GABAergic neuronal markers, such as VGAT128 were expressed in both differentiation datasets. 
Therefore, these results suggest that both hiPSC-Neurons and hESC-derived cortical interneurons 
expressed lineage-specific gene markers, thus indicating an efficient neuronal differentiation and 
validating both protocols. 
After comparing the expression of lineage-specific gene markers between these two distinct 
neuronal differentiation protocols and assessing their major differences, we developed a method to 
accurately analyse common dynamic transcriptional changes in both datasets, that could be specifically 
related to neurogenesis. Our employed strategy is summarised in Fig. 4.7B. Therefore, we present a 
comparison of temporal expression changes between both datasets, regarding the initial list of candidates 
that likely are involved in neuronal differentiation. For simplification purposes, only the main peaks of 
gene expression are depicted here (Fig. 4.7C). Despite differences between the differentiation protocols 
and cell lines, both differentiated neurons and cortical interneurons still exhibited high concordant 
transcriptomes during neuronal differentiation, as highlighted by specific peaks of gene expression 
occurring at approximately the same time points of differentiation, thereby displaying similar trends of 
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expression (Fig. 4.7C). Moreover, we have identified the final candidates likely associated with neuron 
differentiation, revealing three novel putative regulators (TERF2IP, RFX4 and ZHX1) (Fig. 4.7B), and 
their respective RNA-Seq gene expression (Fig. 4.7D).  
Overall, this transcriptome characterization defines a roadmap for neuroectoderm development, 
revealing the temporal peaks of expression of both novel candidates and lineage-specific gene markers 
and highlighting an efficient differentiation of stem cells into neural derivatives. 
Subsequently, the same approach developed to analyse both neuronal datasets was also applied to 
investigate both cardiac differentiation datasets, comparing their transcriptional changes (Fig. 4.8).  
Regarding cardiac differentiation, we selected the genes CDX2, MIXL1, MSX1, MESP1, TBXT, 
NKX2.5, ISL1, HAND2 and MEF2C, since they are generally associated with early CM  
 
 
Fig. 4.7 Transcriptome characterization in early neuronal differentiation.  
(A) High-throughput screen for selected lineage-specific neuroectoderm gene markers. Dynamic comparison between 
two datasets, yielding hiPSC-Neurons and hESC-derived cortical interneurons. (B) Schematic view of the proposed 
method for predicting neural lineage specifiers. As a way to establish gene profiles associated with neuronal 
differentiation, candidate lineage specifiers were identified in three steps. We first compared two datasets of results to 
identify common upregulated TFs between two distinct neuronal differentiation protocols. Then, we performed a 
subtractive analysis of gene profiles that were upregulated in two distinct cardiomyocyte differentiation protocols. This 
strategy has allowed us to eliminate large numbers of genes that were overexpressed in either dataset of results and to 
uniquely associate different gene networks with neural commitment. Finally, we subtracted genes with neurogenesis-
related functions priorly reported in literature, in order to identify putative novel regulators of neurogenesis. (C) 
Comparison of dynamic expression of the initial list of candidates between two datasets, identified in our proposed 
predictive method. (D) Comparison of dynamic expression of the final list of candidates between two datasets, identified 
in our proposed predictive method. In all RNA-Seq expression graphs, X axis shows the differentiation time points, y 
axis shows log2 (fold-change), and z axis shows genes encoding transcription factors. 
 
differentiation58,121. During cardiac differentiation, both differentiated cells expressed lineage-specific 
gene markers, revealing an efficient cardiac differentiation from both protocols. To differentiate hESC 
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into CM, the authors used differentiation factors, which modulated Wnt, FGF and BMP signaling 
pathways. In contrast, to differentiate hiPSC into CM, we used small molecules to modulate the Wnt 
signaling pathway. Despite these differences in the cell lines and differentiation protocols, both hiPSC-
CM and hESC-derived CM (hESC-CM) still exhibited similar patterns of expression, with specific 
genes being up/down regulated at similar time points of differentiation (Fig. 4.8A). Indeed, in both 
datasets results, some genes display a higher expression in the first stage of differentiation, such as: 
TBXT, primitive streak marker, and MIXL1, mesendoderm marker121,129. Then, followed a group of genes 
that exhibited their highest expression approximately at day 3 of differentiation, such as: MSX1, 
mesendoderm marker, and MESP1, mesoderm and cardiac mesoderm marker121,130. CDX2 expression 
was high at the beginning of the differentiation and after day 3, it diminished, consistent with an early  
 
Fig. 4.8 Transcriptome characterization in early cardiac differentiation. 
(A) High-throughput screen for selected lineage-specific cardiac mesoderm gene markers. Dynamic comparison 
between two datasets, yielding hiPSC and hESC-derived CM. (B) Schematic view of the proposed method for predicting 
cardiac lineage specifiers. As a way to establish gene profiles associated with cardiac differentiation, candidate lineage 
specifiers were identified in three steps. We first compared two datasets of results to identify common upregulated TFs 
between two distinct cardiac differentiation protocols. Then, we performed a subtractive analysis of gene profiles that 
were upregulated in two distinct neuronal differentiation protocols. This strategy has allowed us to eliminate large 
numbers of genes that were overexpressed in either dataset of results and to uniquely associate different gene networks 
with cardiac commitment. Finally, we subtracted genes with cardiogenesis-related functions priorly reported in 
literature, in order to identify putative novel regulators of cardiogenesis. It is also shown the final candidates’ gene 
network clustering analysis, obtained by STRING database, that predicts associations based on in vivo and in vitro 
experimental assays. (C) Comparison of dynamic expression of the initial list of candidates between two datasets, 
identified in our proposed predictive method. (D) Comparison of dynamic expression of the final list of candidates 
between two datasets, identified in our proposed predictive method. The expression results of interactive proteins 
predicted in STRING database (JUN, NCOA1 and HOXB5) were added to this graph. In all RNA-Seq expression 
graphs, X axis shows the differentiation time points, y axis shows log2 (fold-change), and z axis shows genes encoding 
transcription factors. 
 
Wnt activation stimulating mesoderm induction, and later Wnt inhibition (from day 3) to induce cardiac 
mesoderm131. At the final stages of differentiation, cardiac mesoderm and cardiac progenitors gene 
markers, such as NKX2-5, ISL1, MEF2C and HAND2121,129, reached their highest levels of expression. 
In sum, these results confirm an efficient CM differentiation in both datasets expression results. 
After comparing the expression of lineage-specific gene markers between these two distinct cardiac 
differentiation protocols, we adapted our previously developed method to accurately analyse common 
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dynamic transcriptional changes in both datasets, that could be now specifically related to cardiogenesis. 
Our employed strategy is summarised in Fig. 4.8B. Therefore, we present a comparison of temporal 
expression changes between both datasets, comprising some initial candidates that likely are involved 
in cardiac differentiation. For simplification purposes, only the main peaks of gene expression are 
depicted here (Fig. 4.8C). It is also presented the protein association networks of the final candidates 
likely associated with cardiac differentiation, revealing thirty novel putative regulators (Fig. 4.8B), and 
their respective RNA-Seq gene expression (Fig. 4.8D). Despite differences between the differentiation 
protocols and cell lines, both hiPSC-CM and hESC-CM exhibited high concordant transcriptomes 
during cardiac differentiation, as highlighted by specific peaks of gene expression occurring at 
approximately the same time points of differentiation, thereby displaying similar trends of expression, 
either regarding the initial or the final list of candidates expression (Fig. 4.8C and D, respectively).  
Taken together, our results provide a comprehensive view of expression changes during 
neurogenesis and cardiogenesis that extend previous studies, identifying key TFs and defining a 
roadmap for neuroectoderm and cardiac mesoderm development. Furthermore, we developed a method 
to screen for putative novel regulators of neurogenesis and cardiogenesis, that will be further validated 
in vitro. 
 
4.5 Validation Experiments 
To validate the expression of some of the final candidate genes identified through transcriptomic 
analysis, at different stages of differentiation, we performed qRT-PCR. Therefore, RNA from cell 
samples of sequential stages of CM differentiation was extracted, converted to cDNA and amplified. 
The analysis was performed using the ΔΔCt method, therefore expression is always represented as 
relative to day 0 and normalized against the expression of the housekeeping gene GAPDH. Moreover, 
in order to evaluate the efficiency of our cardiac differentiation, the presence of the specific marker of 
CMs (CTNT) was assessed by flow cytometry on differentiated cells collected at day 15. Samples 
presented approximately 30% CTNT+ cells (Fig. 4.9). 
 
Fig. 4.9 Cardiomyocyte differentiation efficiency for DF6 cell line assessed by flow cytometry. 
 
For neuronal differentiation, we used previously harvested cDNA at sequential stages of 
differentiation and we directly performed qRT-PCR using those samples, since an efficient neuronal 
differentiation has been previously demonstrated by our group97.  
Therefore, we assessed the expression of final candidate genes: TERF2IP, RFX4 and ZHX1, 
regarding neuronal differentiation; and HOXB2-6 and RARB, for cardiac differentiation. In addition, we 
also analysed the expression of genes specific for neuronal and cardiac differentiation, PAX6 and 
TNNT2, respectively. Primers used for qRT-PCR are presented in Supplementary Table 7.6. Globally, 
the results obtained by qRT-PCR validated the RNA-Seq data.  
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From day 5 of cardiac differentiation, there was expression of transcripts representing CM (TNNT2), 
achieving a peak of relative expression at day 15 (Fig. 4.10A). Moreover, we decided to test HOXB2-6 
(homeobox genes) and RARB (Retinoic Acid Receptor Beta) expression at the transcript level, since 
evidence suggests that HOXB genes have close associations with RARB132. Indeed, transgenic analyses 
in mice identified novel enhancers, that respond to exogenously added RA and modulate the expression 
of genes from the HOXB complex during embryonic cardiac development133. However, in humans, these 
relationships have not been proven yet. Additionally, HOXB4 and HOXB6 were also final candidate 
putative regulators identified in our analysis and HOXB5 was predicted by STRING database as an 
interactive protein. Therefore, to avoid redundant functions between these HOXB genes, we decided to 
assess HOXB2-6 expression.  
HOXB6 expression levels were lower than from the remaining HOXB genes (HOXB2-5), which is 
consistent with the RNA-Seq data derived from both datasets (data not shown). HOXB2-5 and RARB 
relative expression started on day 1, reached a peak of expression at day 5, reaching a plateau until day 
15. Notably, HOXB4 relative expression levels were higher than the remaining genes, and HOXB4 and 
HOXB5 expression levels slightly increased particularly from day 9 to day 15, in agreement with the 
transcriptomic data. Moreover, evidence shows that HOXB2 has been previously identified as a potential 
cardiac regulator134,135, which our qRT-PCR data also corroborate. In addition, HOXB3 has been shown 
to be involved in the development of blood vessel, vasculogenesis and angiogenesis136. 
Regarding neuronal differentiation, since it was not possible yet to assess the relative expression of 
genes during more time points throughout neuronal differentiation, we only present the results from day 
12 and 16 in comparison with day 0, which is not enough to define an expression kinetic. However, it 
was noticeable that the relative expression of TERF2IP and of neural TF PAX6 was lower on day 16 
than on day 12 (Fig. 4.10B). Conversely, the expression level of RFX4 was higher on day 16 than on 
day 12. Indeed, during RNA-Seq, RFX4 was significatively expressed from day 9 until day 16, 
increasing progressively along those two time points (data not shown). Hence, regarding RFX4, our 
transcriptomic data revealed a log2(fold-change) of 5.8 on day 12 and of 7.9 on day 16 in hiPSC-Neurons 
(data not shown), consistent with the qRT-PCR results. In addition, RFX4 has been reported to be 
required for neural tube and brain development and morphogenesis, as a modulator of Shh signaling 
during development of the CNS, and as a regulator of ciliogenesis, playing also ciliogenesis-independent 
roles during neural development137-139. 
ZHX1 did not reveal a significative expression in qRT-PCR. Moreover, TERF2IP did not match the 
transcriptomic data, since its expression was not detected on day 12, only on day 16 during RNA-Seq. 
TERF2IP has been reported as being involved in telomere length regulation140. Despite this exception, 
overall our qRT-PCR results validated the RNA-Seq data. However, it is important to consider that the 
flow cytometry and qRT-PCR results were obtained from only one experiment (n=1) and should be 
furtherly validated with more experiments in order to become statistically significative. 
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Fig. 4.10 Expression profiles during hiPSC cardiomyocyte and neuronal differentiation.  
(A) Gene expression was assessed by qRT-PCR and RNA-Seq at sequential stages for putative novel regulators of 
cardiomyocyte differentiation identified through the transcriptomic analysis (HOXB4, HOXB6 and RARB). It is also 
displayed the expression of HOXB5, a gene that has been predicted by STRING database as an interactive protein, 
representing another putative novel regulator. The expression of HOXB2 and HOXB3, as well as of key genes that unveil 
the progression throughout cardiac differentiation (TNNT2) was also assessed by qRT-PCR. (B) Gene expression was 
assessed by qRT-PCR and RNA-Seq at sequential stages for putative novel regulators of neuronal differentiation 
identified through the transcriptomic analysis (TERF2IP, RFX4 and ZHX1). The expression of key genes that unveil 
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the progression throughout neuronal differentiation was also assessed by qRT-PCR, with PAX6. The analysis was 
performed using the ΔΔCt, therefore expression is always represented as relative to day 0 and normalized against the 
expression of the housekeeping gene GAPDH. n=1 qRT-PCR experiment for each time point. For RNA-Seq graphs, X 
axis shows the differentiation time points, y axis shows log2 (fold-change), and z axis shows genes encoding transcription 
factors. Novel regulators predicted in our transcriptomic analysis are highlighted in bold.  
5 Conclusion and Future Perspectives 
Here, we developed a comprehensive transcriptomic and network modeling approach to investigate the 
critical changes that may occur during human early neuronal, cardiac and hepatic differentiation. 
Additional published datasets were analysed to cover multiple cellular lineages and construct their 
developmental trajectories.  
We identified temporal gene and pathway activation patterns during controlled differentiation of 
hPSC. These approaches paved the way for a deeper understanding of the regulatory mechanisms 
governing distinct cellular subpopulations present at each differentiation stage. Our analysis led us also 
to identify novel putative regulators of cardiogenesis and neurogenesis. We expect that this knowledge 
might one day be exploited for regenerative medicine, disease modeling and drug discovery 
applications. 
Furthermore, we anticipate our assay to be a starting point to better understand the mechanisms that 
control human pluripotent stem cell fate transitions, and we hope that this will remain a highly dynamic 
field in the future. Indeed, we propose below some main strategies with important contributions, that 
should be furtherly developed. 
Therefore, putative novel key regulators of cardiogenesis and neurogenesis predicted in our 
transcriptomic analysis should be subsequently validated by small interfering RNA (siRNA). This 
strategy would be required to undoubtedly confirm that they play a crucial role in cardiac and neuronal 
differentiation, whenever their targeted knockdown prevents differentiation.  
Moreover, hiPSC-derived hepatocytes should also be analysed by RNA-Seq in order to perform a 
broader analysis of human early development, integrating cell lineages derived from all three human 
germ layers. This would therefore provide essential additional insights about differentially regulated 
mechanisms that govern each lineage decision-making. 
In addition, the same type of study that we developed in a 2D culture system could be employed to 
a 3D system, in order to unveil the similarities and different features of both culture systems. Cells 
cultured in 3D mimic the in vivo microenvironment more closely. However, they can present higher 
cellular heterogeneity/plasticity and different morphology, in comparison with conventional 2D 
systems, due to differences among gradients of oxygen, growth factors, nutrients and complex cell-
matrix or cell-cell interactions. Thus, it would be beneficial to perform a single-cell RNA-Seq in these 
3D cell culture systems, taking into consideration single-cell measurements of the heterogeneous 
transcriptional responses. Although this technique was not required in our differentiated cells in a 2D 
culture system, since our protocols derived highly homogenous cell populations, it would be more 
adequate for a 3D culture comparative analysis. 
Hopefully, the present study opens a wide range of exciting possibilities that would aid in enhancing 
the efficiency of hPSC differentiation as well as their clinical applications. Overall, our analysis reveals 
the cellular-state landscape of hPSC early differentiation, offering new insights in terms of gene 
expression profiles and signaling pathways crosstalk, that will shed light on novel molecular 
mechanisms governing cell fate decisions.  
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7 Supplementary Information 
 
Supplementary Table 7.1 Literature-based curation list of ectoderm, mesoderm and endoderm-associated genes.
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Supplementary Table 7.2 Gene clustering analysis. 
Each cluster represents a protein-protein interaction network based on protein encoding genes involved in human 
ectodermal, mesodermal and endodermal specification. These interaction networks were obtained by STRING 
database, that predicts associations based on in vivo and in vitro experimental assays. Proteins were clustered using the 
Markov Cluster Algorithm (MLC) with an inflation parameter = 3. 10 more proteins were predicted for the network. 
This table represents the biological processes (FDR < 0.05) and KEGG pathways (FDR < 0.05) associated with the 
analysed proteins. (*) Protein encoding genes from individual cluster colours that did not present statistically significant 
results were grouped and analysed together. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cluster Color Gene Count
Olive 2
Medium Sea Green 9 WNT7A; SCN10A; VPS53; CTNNB1;
Purple 4 WNT3; HAND1; VPS52; PPP1R8;
Pink 4 CHUK; CALM2; CUL3; NF2.
Green Yellow 2 AXIN1; SCN5A; ENC1; IGF1;
Brown 2 FZD7; CHD1L; SMURF1; TGS1;
Dark Golden Rod 2 ANXA5; HDAC3; KLHL25; MTHFR;
Yellow 2 ADA; ZBTB7B; MTRR.
Green 2
Hot Pink 8
Pink 8
Light Coral 5
Olive 3
Yellow 3
Brown 3
Medium Orchid 2
Cornflower Blue 4
Medium Slate Blue 2
Pale Violet Red 6
Fire Brick 4
Sandy Brown 3
Dark Golden Rod 3
Blue 2
Cyan 2
Orchid 2
Green 2
Light Sea Green 13
Blue 8
Purple 6
Pink 5
Dark Golden Rod 3
Yellow 2
Olive Drab 1
Biological Process Protein Name Pathway Description
Red
13
chromatin organization; regulation of transcription from RNA polymerase II promoter; DNMT3A; HDAC1; HDAC2; EZH2; EZH1;
Notch signaling pathway
ectodermal placode development; nervous system development. EED; AEBP2; DNMT3B; DNMT1; SP3; 
SUZ12; CTCF; YY1.
Light green 12
developmental process; regulation of transcription; cell differentiation; ectoderm development; CDX2; LHX1; SHH; TP63; STX2; EOMES; Hedgehog signaling pathway
embryonic organ development; stem cell differentiation; axis specification. BMP4; NODAL; BMPR1A; PAX6; ELF5; TGF-beta signaling pathway
pattern specification process; forebrain regionalization; telencephalon regionalization .
JUNB; HOPX; ETS2; FOS; SRF. TNF signaling pathway
gastrulation with mouth forming second; embryo development; anatomical structure formation involved in morphogenesis.
FOXF1.
Cyan 7
integrin-mediated signaling pathway; ectoderm development; extracellular matrix organization; ITGAM; ITGA6; ZBTB17; ITGA4; ITGAE; 
PI3K-Akt signaling pathway
ectodermal cell differentiation; cell-matrix adhesion. ITGB7; FERMT1.
Ec
to
d
e
rm
- AGR3; AGR2. -
regulation of translation; biosynthetic process. (*)
Wnt signaling pathway
TNF signaling pathway
PI3K-Akt signaling pathway
Hippo signaling pathway
Pale Violet Red 3
positive regulation of cytoplasmic mRNA processing body assembly; nuclear-transcribed mRNA poly(A) tail shortening.
CNOT1; CNOT2; CNOT3. -
 negative regulation of intracellular estrogen receptor signaling pathway; regulation of stem cell population maintenance.
Medium Purple 5
positive regulation of transcription elongation from RNA polymerase II promoter; histone H2B ubiquitination; 
CDC73; RTF1; LEO1; CTR9; PAF1. -
gastrulation; stem cell differentiation.
Orchid 5
trophectodermal cell differentiation; blastocyst formation; blastocyst development; primitive streak formation; 
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17
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process.
mesoderm development; positive regulation of transcription, DNA-templated; tissue development; 
positive regulation of transcription from RNA polymerase II promoter; gene expression; embryo development.
Red
Aquamarine
Purple
M
e
so
d
e
rm
mesoderm development; mesoderm formation; mesoderm morphogenesis; pattern commitment process;
 activin receptor signaling pathway; embryonic morphogenesis;  formation of primary germ layer; gastrulation;
 transmembrane receptor protein serine/threonine kinase signaling pathway; tissue morphogenesis; 
skeletal system development; mesenchyme development; regionalization; cardiovascular system development.
mesoderm formation, morphogenesis and development; embryo development; gastrulation. (*)
Salmon 4
Sky Blue 6
9
Violet 11
Medium Purple 12
viral gene expression; viral transcription; single-organism membrane organization;
 cellular component disassembly; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; 
mesoderm development; translational initiation, elongation and termination; protein transport.
mesenchyme development; cardiac septum morphogenesis and development; muscle structure development; 
heart morphogenesis; morphogenesis of an epithelium; cardiac chamber morphogenesis; heart development; 
mesoderm development; regionalization; gastrulation; pattern commitment process; embryonic morphogenesis; 
anterior/posterior pattern commitment; mesoderm morphogenesis; tissue morphogenesis; mesoderm formation
formation of primary germ layer; negative regulation of developmental process; epithelium development; 
mesenchyme development; embryonic organ development; regulation of organ morphogenesis.
GATA4; HAND1; NPPA; TCF21; ZFPM2; TBX20; NKX2-5; KDM6A;
TBX1; TBX5; TCF15.
BMX; ETV2; CXCR4; APLNR; VEGFA; FGF1; FGFR2; IGF2; TIE1; 
mesoderm development; nephron development; kidney morphogenesis; tissue morphogenesis.
cellular response to heat; cell cycle arrest; regulation of transcription from RNA polymerase III promoter.
cellular response to stress; regulation of intracellular signal transduction; cellular response to insulin stimulus.
autonomic nervous system development; regulation of respiratory gaseous exchange; neural crest cell migration.
exocytosis.
cardiovascular system development; circulatory system development; striated muscle tissue development.
mesoderm development; blood vessel morphogenesis; positive regulation of cell division; 
cardiovascular system development; circulatory system development; positive regulation of MAPK cascade;
cell surface receptor signaling pathway; anatomical structure morphogenesis; angiogenesis.
somitogenesis; somite development; chordate embryonic development; paraxial mesoderm development.
mesodermal cell differentiation; integrin-mediated signaling pathway; cell-matrix adhesion.
CDX2; WLS; TBX3; BMPR2; SHH; WNT5A; WNT11; WIF1; 
MESP1; CER1; EOMES; TWSG1; AMH; FGFR1; NOG; BMP4;
SOX17; WNT3; GDF3; BMPR1A; FOXF1; BMP7; KLF4; WNT3A;
DKK1; PAX2; HOXB5; MIXL1; SMO; FGF8; SFRP2; CHRD; FOXA2.
SMAD1; INHBA; SMAD3; GDF11; TLX2; FOXH1; ACVR1; HMGA2;
ACVR2A; NODAL; TAL1; SMAD2; POGLUT1; SMAD4; ACVR2B; 
TMEM88; SNAI1.
RPLP2; PPP2CA; RPS20; NUP133; RPS27; NUP107; RPL30; 
RPL36; CTDNEP1; RPL38.
EXOC3; EXOC5; EXOC4.
EXT2; EXT1; NR4A3.
RNF111; RNF130; MSGN1; CDX4; AXIN1; CTNNB1.
 JAK2; TET2; LEF1; IKZF3; IKZF1; BTK; CITED2; LHX2; TEAD2; 
PRRX2; HOPX; PRRX1; ETS2; SRF; MATK; FOXD3; POU5F1; 
TBX18; DLL3; HES7; MESP2; TBX6; FOXC2; FOXC1; DLL1.
ITGA8; ITGA2; ITGB4; ITGA3; ITGB1; FERMT2; FERMT1; ITGB3.
SIX2; IRX3; OSR1; EYA1; EYA2.
PHOX2A; PHOX2B; EDNRB.
Wnt signaling pathway
Hedgehog signaling pathway
Hippo signaling pathway
TGF-beta signaling pathway
Hippo signaling pathway
TGF-beta signaling pathway
Ras signaling pathway
Rap1 signaling pathway
PI3K-Akt signaling pathway
-
-
-
-
-
Hippo signaling pathway
Wnt signaling pathway
Hippo signaling pathway
mTOR signaling pathway
Notch signaling pathway
PI3K-Akt signaling pathway
mTOR signaling pathway
PI3K-Akt signaling pathway
-
Red 19
Light Green 18
cell differentiation; developmental process; system development; pattern specification process;
 transcription from RNA polymerase II promoter.
signal transduction; response to stimulus; cell communication; cell proliferation; MAPK cascade; 
developmental process; regulation of phosphate metabolic process; biological regulation;
transmembrane receptor protein tyrosine kinase signaling pathway; angiogenesis; locomotion; behavior.
 Hedgehog signaling pathway
Notch signaling pathway.
mTOR signaling pathway; 
MAPK signaling pathway; 
 TGF-beta signaling pathway
Wnt signaling pathway
NANOG; PRDM14; MTHFR; TXNRD1; MTRR; PRKAR1A; NF2;
PRKACA; TP63; MEST; DAND5; CDH1; FOXL1; MESDC2; SENP1;
YAP1; SETD2; KDM6B; HCK; EPHA2.
mesoderm development; anatomical structure morphogenesis;  developmental process.
developmental process; transmembrane receptor protein serine/threonine kinase signaling pathway; 
cell surface receptor signaling pathway; cell differentiation; signal transduction; mesoderm development;
protein phosphorylation; regulation of transcription from RNA polymerase II promoter; MAPK cascade.
biological adhesion; cell adhesion; signal transduction; cell communication.
Green
Cyan
Violet
Brown
13
13
6
4
BMPR1A; WNT7B.
LAMB1; VTN; ITGB2; ITGB5; FN1; ITGA7; ITGA4; LAMB3; LAMC1; FERMT1; LAMA3; ITGA5; ITGAV.
COL12A1; COL11A1; COL8A1; COL4A2; COL6A1; COL7A1; COL5A1; COL5A2.
INHBA; HMGA2; NODAL; SMAD3; SMAD2; SMAD4.
CDC73; RTF1; SETD2; LEO1; CTR9; PAF1.
KDM6A; HDAC1; BPTF; EZH2; KDM6B.
regulation of phosphate metabolic process; signal transduction; cell communication; biological regulation.
Without statistically significant results. (*)
RNA metabolic process; primary metabolic process; cell communication; transcription, DNA-dependent.
biosynthetic process; transcription elongation from RNA polymerase II promoter; nitrogen compound metabolic process.
chromatin organization.
regulation of catalytic activity; regulation of molecular function; MAPK cascade; response to stimulus; 
mesoderm development.
transmembrane receptor protein serine/threonine kinase signaling pathway; intracellular signal transduction; 
cell surface receptor signaling pathway; regulation of transcription from RNA polymerase II promoter; 
MAPK signaling pathway
-
En
d
o
d
e
rm
MTOR; RPTOR; MLST8; RPS6KA6.
DUSP6; DUSP2; DUSP4; DUSP1.
TIMP2; MMP8; MMP15; MTHFR; MTRR; MMP14.
-
TGF-beta signaling pathway
Hippo signaling pathway
Hedgehog signaling pathway
PI3K-Akt signaling pathway
PI3K-Akt signaling pathway
TGF-beta signaling pathway
FoxO signaling pathway
Hippo signaling pathway
-
-
PITX2; NOTCH1; GATA4; DKK1; TBX20; AXIN1; ZEB2; SOX2; SOX7; RBPJ;
POU5F1; ID2; CTNNB1; APC; WNT2; MED12; WNT8A; GDF3; NANOG.
ZFP36L1; MTOR; VEGFA; TGFB1; RPS6KB1; MMP2; RICTOR; CXCR4; 
APLNR; AKT1; KDR; PDGFA; RPTOR; DUSP5; MLST8; MMP9; VEGFC; FGF2.
HHEX; LHX1; SOX17; MESP1; ZNF202; HNF1B; AFP; EOMES; GATA6; PDX1;
 HNF4A; ONECUT1; FOXA2.
BMP7; NOG; MIXL1; FGF4; NKX2-1; FGF8; CER1; GSC; PAX9; EXT1; BMP4; 
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Supplementary Table 7.3 Transcription factors guiding human pluripotent stem cells towards cardiac mesoderm and 
neuroectoderm specification.  
According to RNA-Seq expression results, statistically significant upregulated genes encoding transcription factors were 
selected based on the following cutoff: adjusted p-value < 0.05 and fold-change > 2. 
* Genes previously predicted in silico (on Supplementary Table 7.1). 
 
 
Supplementary Table 7.4 Expression profiling analysis of fetal and adult tissues by high throughput sequencing. 
Description of collected datasets deposited with GEO to compare RNA-Seq gene expression profiles from neural, 
cardiac and hepatic fetal and adult cell types. 
 
 
Supplementary Table 7.5 Expression profiling analysis by high throughput sequencing. 
Description of collected datasets deposited with GEO to compare RNA-Seq gene expression profiles from neural, 
cardiac and hepatic differentiation. 
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Supplementary Fig. 7.1 Differentially expressed genes (DEGs) overview in ectoderm and mesoderm differentiation.  
Venn diagrams highlight the number of DEGs in ectoderm (blue) and mesoderm (red) differentiation. Significantly 
DEGs were selected based on the following cutoff: adjusted p-value < 0.05 and fold-change > 2. Day 6 of ectoderm 
differentiation was compared to day 5 of mesoderm differentiation in order to obtain more early time points to analyse. 
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Supplementary Fig. 7.2 Transcription factors regulating human pluripotent stem cell fate transitions.  
Scatter plots comparing the indicated samples. Genes encoding TFs were screened, according to their log2(CPM), at 
sequential stages of differentiation. An additional published endodermal dataset (Li et al., 2017) was used to broaden 
our analysis to all three-germ layer-derived cell lineages. 
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Supplementary Fig. 7.3 Differential expression of key regulators in ectoderm and mesoderm differentiation. 
Venn diagrams highlight the number of DEGs in ectoderm (blue) and mesoderm (red) differentiation. Significantly 
DEGs encoding transcription factors (TFs) were selected based on the following cutoff: adjusted p-value < 0.05 and 
fold-change > 2. Day 6 of ectoderm differentiation was compared to day 5 of mesoderm differentiation in order to obtain 
more early time points to analyse. 
 
Supplementary Table 7.6 Primer sequences used for quantitative real-time polymerase chain reaction. 
Melting temperatures (Tm), amplicon size and primer specificity were estimated using Primer Blast. 
Gene Primer Tm GC % Product length 
HOXB2 FW  TCCCCTAGCCTACAGGGTTC 60.03 60 180 
 RW  GGTGGGAGAGGCTCGATTTT 59.75 55  
HOXB3 FW  CACTTCTAGCCCCCGGTTTT 59.96 55 185 
 RW  AGTCCTAACAACCTGCCTGC 59.96 55  
HOXB4 FW  CTCCCGATACCCAGCGAAAG 60.25 60 97 
 RW  ATGGGCACGAAAGATGAGGG 60.11 55  
HOXB5 FW  GGCCGCATACATAGCAAAACG 60.6 52.38 157 
 RW  CGCCCCGAGAAGGAGTTTAC 60.46 60  
HOXB6 FW  TGGAGGGTAAATGGACAATCTGC 60.62 47.83 118 
 RW  TGACTTGGGAGAGAGGGTGTT 60.41 52.38  
RARB FW  CTTCCTCCCCCTCGAGTGTA 60.03 60 111 
 RW  ACTTCTGCGGAAAAAGCCCT  60.18 50  
TERF2IP FW  GGGCCAGGAGCATAAGTACC  59.89 60 114 
 RW  TTCTGTGGTTCCCCGCTATC 59.46 55  
RFX4 FW  GTGAGTGAGACGGGCAAGAA 59.97 55 79 
 RW  GCAGCAGTGTTCCGAGTTTG 60.04 55  
ZHX1 FW  GGCAAGCAGGCGAAAATCAA 60.04 50 108 
 RW  GGTGTAAGCACAGGAGGACC 60.04 60  
 
